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Abstract
Many (re) emerging pathogens are arthropod-borne, transmitted via an insect vector, and cause significant
health and agricultural problems worldwide. Despite their significance, there are few vaccines and no targeted
therapies that exist. This is at least in part due to our limited understanding of virus-host interactions and the
mechanisms used by hosts to restrict infection. In particular, insect vectors play a critical role in the
transmission and spread of these pathogens, but performing molecular and genetic studies has proven to be
difficult. Drosophila is a model organism that shares a high degree of conservation with insect vectors and has
a wealth of molecular and genetic tools for study. Hence, this thesis aims to provide a deeper understanding of
the innate immune factors that restrict arthropod-borne viruses using this model organism. Using genetic
approaches both in vitro and in vivo, two novel antiviral pathways are discovered and examined in this thesis.
First, using RNA interference (RNAi) screening against disparate viruses in Drosophila, the transcriptional
pausing pathway is found to be essential for antiviral insect immunity. This led to the characterization of a
rapidly induced antiviral transcriptional program, half of which is genetically dependent on this regulatory
mechanism and has pausing-associated chromatin features. These findings suggest transcriptional pausing
primes virally induced genes by enhancing promoter accessibility to allow for rapid gene induction, thereby
coordinating a robust and complex antiviral response. Subsequently, the ERK pathway is found to be part of
this transcriptional response to viral infection. Not only is this nutrient responsive pathway induced by viral
infection, but it also restricts disparate arboviral pathogens. Furthermore, ERK signaling is essential for
antiviral defense in the insect intestinal epithelium. While wild type flies are refractory to oral infection by
arboviruses, this innate restriction can be overcome chemically by oral administration of an ERK pathway
inhibitor or genetically via the specific loss of ERK in the intestinal epithelial cells. In addition, vertebrate
insulin that activates ERK signaling in the mosquito gut during a blood meal, can restrict viral infection in
insect cells and protect against viral invasion of the gut epithelium. These studies collectively demonstrate that
ERK signaling in the insect intestines potently restricts viral infection, suggesting that insects take advantage
of signals in the meal to preemptively activate antiviral immunity.
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ABSTRACT 
 
DISCOVERING NOVEL INTRINSIC ANTIVIRAL RESPONSES TO ARBOVIRUSES: 
FROM TRANSCRIPTION TO INTESTINAL INNATE IMMUNITY 
Jie Xu 
Sara Cherry 
Many (re) emerging pathogens are arthropod-borne, transmitted via an insect vector, 
and cause significant health and agricultural problems worldwide. Despite their 
significance, there are few vaccines and no targeted therapies that exist. This is at least 
in part due to our limited understanding of virus-host interactions and the mechanisms 
used by hosts to restrict infection. In particular, insect vectors play a critical role in the 
transmission and spread of these pathogens, but performing molecular and genetic 
studies has proven to be difficult. Drosophila is a model organism that shares a high 
degree of conservation with insect vectors and has a wealth of molecular and genetic 
tools for study. Hence, this thesis aims to provide a deeper understanding of the innate 
immune factors that restrict arthropod-borne viruses using this model organism. Using 
genetic approaches both in vitro and in vivo, two novel antiviral pathways are discovered 
and examined in this thesis. First, using RNA interference (RNAi) screening against 
disparate viruses in Drosophila, the transcriptional pausing pathway is found to be 
essential for antiviral insect immunity. This led to the characterization of a rapidly 
induced antiviral transcriptional program, half of which is genetically dependent on this 
regulatory mechanism and has pausing-associated chromatin features. These findings 
suggest transcriptional pausing primes virally induced genes by enhancing promoter 
accessibility to allow for rapid gene induction, thereby coordinating a robust and complex 
antiviral response. Subsequently, the ERK pathway is found to be part of this 
transcriptional response to viral infection. Not only is this nutrient responsive pathway 
induced by viral infection, but it also restricts disparate arboviral pathogens. 
Furthermore, ERK signaling is essential for antiviral defense in the insect intestinal 
epithelium. While wild type flies are refractory to oral infection by arboviruses, this innate 
restriction can be overcome chemically by oral administration of an ERK pathway 
inhibitor or genetically via the specific loss of ERK in the intestinal epithelial cells. In 
	  vi	  
addition, vertebrate insulin that activates ERK signaling in the mosquito gut during a 
blood meal, can restrict viral infection in insect cells and protect against viral invasion of 
the gut epithelium. These studies collectively demonstrate that ERK signaling in the 
insect intestines potently restricts viral infection, suggesting that insects take advantage 
of signals in the meal to preemptively activate antiviral immunity. 
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CHAPTER 1. INTRODUCTION1 
1. (Re) emerging Infectious Arboviral Pathogens 
Arthropod-borne viruses, known as arboviruses, are a common cause of 
morbidity and mortality worldwide. With increased global spread of West Nile virus and a 
higher risk for contracting Dengue Fever, the dangers posed by arboviruses are 
extending beyond their traditional geographical boundaries (Figures 1 and 2) [1-4]. 
These pathogens circulate amongst wild animals and cause disease after transmission 
to humans and domestic livestock, which are often incidental or dead-end hosts (Figure 
3) [1,4]. They are transmitted via the bite of a hematophagous insect vector, often an 
infected mosquito that feeds on an incidental vertebrate host [4,5]. Once transmitted, 
these viruses cause a broad range of symptoms in humans and livestock, from mild 
malaise to fatal encephalopathy [6-8]. Despite the increasing clinical and agricultural 
significance of arboviral pathogens, few vaccines and no targeted therapies currently 
exist [7,9]. 
Most arboviruses impacting public health fall into three viral families: 
Alphaviridae, Flaviviridae, and Bunyaviridae [1,5,10]. Alphaviruses are enveloped 
viruses with a single-stranded, positive-sense RNA genome. Sindbis virus (SINV) is the 
prototypical alphavirus that has been used to investigate virus-host interactions. In 
humans, SINV infection can cause chronic polyarthritis and Pogosta disease [11,12]. 
Other Alphaviruses cause more severe illnesses and are considered serious human 
pathogens, including Chikungunya virus, Ross River virus, and Venezuelan Equine 
Encephalitis virus [4,10]. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 Portions of this chapter is from Xu J and Cherry S. Antiviral immunity in Drosophila. Invited 
Review In Preparation. 
2 Adapted from Sabin LR, Hanna SL, Cherry S. Innate Immunity in Drosophila. Curr Opin 
Immunol. 2010 Feb;22(1):4-9. 
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Flaviviridae are single-stranded positive sense RNA viruses, from which Dengue 
virus (DENV) is one the best-recognized human pathogens [2,10]. West Nile Virus 
(WNV) is another broadly distributed arbovirus that has caused numerous outbreaks, 
including many recently in America [3,13,14]. Kunjin virus is a less pathogenic strain of 
WNV found in Oceana [10]. Other Flaviviruses of clinical concern include Japanese 
encephalitis virus and yellow fever virus [1,10]. 
Bunyaviruses are negative-sense and tri-segmented RNA viruses. Rift Valley 
Fever virus (RVFV) is a bunyavirus that is a USDA and the Human Health and Services 
select agent [15-17]. RVFV can cause fatal hemorrhagic disease in infected humans and 
has a high mortality rate among livestock [15,17]. This mosquito-transmitted virus is 
endemic to Africa, but has recently spread to the Arabian Peninsula [16,18]. 
Furthermore, mosquito species elsewhere, including in the US, have been shown to be 
capable of carrying and transmitting RVFV [16,18,19].  
Rhabdoviridae is a much less clinically significant arboviral family, but includes 
one of the most well characterized viruses for biomedical research: vesicular stomatitis 
virus (VSV). VSV is a negative sense RNA virus that can cause foot-and-mouth disease 
in infected humans and can be fatal to infected cattle via the bite of sandflies [10,20,21]. 
The relative genomic simplicity of this virus, its extensive host range, and the existing 
array of molecular tools make VSV a useful tool for studying virus-host interactions. 
In summary, there exist a wide variety of arboviral pathogens that can be 
transmitted to humans and livestock via the bite of a blood-feeding insect. An important 
consequence of the arboviral transmission cycle is that they must successfully replicate 
in both vertebrate and invertebrate systems. These viruses encode a myriad of 
replication strategies, as a consequence of evolution in such disparate hosts. On the 
other side, natural and incidental hosts have also evolved complex immunologic 
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pathways to curtail their replication and spread, many of which remain uncharacterized. 
Given the recent discovery that mosquitoes harboring the bacteria Wolbachia are 
resistant to Dengue infection and introduction of Wolbachia into mosquito populations is 
now being used to hamper disease spread [22,23], identification of pathways that can 
help boost insect defenses may be feasible as novel vector control strategies. 	  
 
2. The Infection Cycle of Arboviral Vectors 
Arthropod vectors are hematophagous insects that transmit pathogens from one 
vertebrate host to another. In many vector species, including mosquitoes that transmit 
the most common arboviruses, only the females ingest blood and are the source of 
transmission [5]. In other species, including many ticks, both females and males are 
hematophagous and can transmit viruses [5,10]. Regardless of these differences, viral 
pathogens must productively infect the arthropod vector before it can infect the next 
vertebrate host [5,10]. This biological transmission is different than mechanical 
transmission, where pathogens merely get physically transferred from one vertebrate 
host to another without any infection of the insect [5,10]. In addition to horizontal 
transmission, some arboviruses can also be vertically transmitted from mother to 
progeny through the transovarial or transovum route of the insect [5,10].  
For biological transmission, the insect vector contracts the viral pathogen by 
blood feeding on a vertebrate with a pre-existing infection. The period from ingestion of 
the infectious blood meal to being capable of transmitting the pathogen to another 
animal is called the extrinsic incubation period, which generally ranges from 6-14 days in 
the insect [5]. During this time, virus first encounters the insect digestive tract, where it 
must infect and replicate successfully in the midgut epithelial cells. Next, the virus must 
penetrate through this gut barrier to establish viremia using the insect’s open circulatory 
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system [5,24-28]. Blood and interstitial fluid are collectively referred as hemolymph, 
which bathes all internal tissues, organs and hemocytes [29-31]. While the hemolymph 
facilitates the transport of nutrients, waste products, and metabolites, it also facilitates 
systemic dispersal of virions. If the virus can penetrate the gut barrier, it can spread to 
secondary organs, including the nervous system, the muscle, and the insect equivalent 
of a liver termed the “fat body” [31,32]. Finally, the salivary glands must be infected for 
successful transmission. These glands shed virions into the salivary ducts, which are 
then injected into the vertebrate during a blood meal [24,33-35]. Once infected, the 
insect vector can potentially transmit virus to each subsequent new vertebrate host upon 
feeding.  
In this way, the arbovirus establishes a chronic, albeit nonpathogenic, infection in 
the arthropod host. However, this is not a passive process, because 
immunocompromised vectors can have increased viral titers, pathogenesis, and even 
succumb to infection [5,34,36]. Hence, elucidating the differentiating factors that make 
up vector competence not only informs us of basic immunology, but also allows for the 
development of interventions to control vector populations. 
 
3.  Antiviral Vector Immunity: Tissues Barriers and Immunologic Compartments 
The insect vector presents with a complex immune system and mucosal barriers 
that must be overcome for successful infection by an arbovirus. Several barriers to 
infection have been either shown or hypothesized to be critical for arboviral cycle 
integrity, including the midgut and salivary glands [5,34,36]. Furthermore, the insect 
immune system also plays important roles in controlling systemic infection, which 
includes the fat body, hemocytes, and other tissue compartments that remain to be 
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characterized [5,34,36]. These various barriers all help define vector competence for 
transmission (or lack of competence). 
To establish infection, arboviruses must first infect the midgut epithelium. While 
studies have successfully infected a wide range of vectors by directly injecting 
arboviruses into the thoracic cavity, oral challenge often does not result in productive 
infection [5,32,36]. This has led to the description of a “midgut barrier,” which has long 
been recognized as a major determinant of vector competence and can present in one 
of two ways [5,34,36]. First, the arbovirus may be unable to establish a productive 
infection in the midgut cells due to restriction by local defenses. And second, the 
arbovirus may be unable to escape the midgut to establish viremia. However, it is known 
that this “midgut barrier” is penetrable in many cases, as a species-specific dose-
response phenomenon or infection thresholds have been described for a variety of 
vector-virus systems. This is classically defined as the titer in which 5% of vectors 
become infected [5]. Below the threshold, few of the vectors ingesting the blood meal 
become infected; above this threshold, significant numbers become infected [5]. 
Many hypotheses have been proposed to explain the “midgut barrier.” It has 
been suggested that the formation of the peritrophic matrix in the gut lumen upon blood 
meal ingestion prevents the virus from contacting and infecting midgut cells for some 
species [5,37]. However, these membranes typically occur 24-48 hours after a blood 
meal [5,34,36], which is likely too late to interfere with the initial establishment of 
infection. It is also possible that refractory arthropods may have specialized defensive 
mechanisms that protect against viral infections, including mucopolysaccharides or other 
antiviral agents that are secreted into the midgut itself [5,36,38,39]. However, there is 
little evidence supporting this hypothesis. Viral inactivation or inappropriate processing of 
viral glycoproteins by the midgut enzymes is another potential explanation for the 
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strength of this infection barrier. Since arboviruses are enteric viruses of insect vectors, 
they may require appropriate proteolytic processing for infectivity. For example, 
Lacrosse virus infectivity is enhanced by proteolytic processing of their virions [5]. 
Alternatively, vectors may lack the specific receptors required for viral entry in the gut. 
While there are many hypotheses to explain facets of the “midgut barrier,” whether 
specific cell-intrinsic immune pathways affect the infectivity of the gut epithelium remains 
largely unknown. 
Salivary gland infection is another barrier that must be breached by arboviruses. 
Like the midgut barrier, this can also present in two ways. In some cases, the gland may 
be completely refractory to infection [5,36]. In other instances, the virus may establish 
infection, but not be appropriately injected into the vertebrate and precludes 
transmission [36,40]. For example, Ae. hendersoni cannot transmit Lacrosse virus, 
although there is viral infection and replication in salivary glands [5]. Again, whether cell 
intrinsic immunity plays a role in this organ is largely unknown. 
The adult insect also has two major specialized immune organs: the fat body and 
hemocytes. The fat body is the largest organ of the hemocel, the insect body cavity, and 
is a major site for the production of the humoral response to infection [32,41]. The 
humoral response includes the production of immune effector proteins and antimicrobial 
peptides, which are synthesized predominantly in fat body and released into the 
hemolymph [32,42]. While the fat body is the major factory for such products, hemocytes 
and epithelial layers of the integument and the gut are also sites for the synthesis of 
such molecules. Many of these antimicrobial peptides are either not expressed or are 
expressed at a very low level prior to infection [42]. In addition, the humoral response 
includes the induction of enzyme cascades that regulate coagulation and melanization of 
hemolymph, and production of reactive oxygen and nitrogen species [31,43-47]. 
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Lastly, insects have both circulating and sessile hemocytes. Circulating 
hemocytes help confer systemic protection by participating in phagocytosis and 
encapsulation of foreign intruders in the hemolymph, such as parasitic wasp eggs 
[41,47,48]. Cellular responses mediated by hemocytes include phagocytosis, nodulation 
and encapsulation [48-51]. Interestingly, hemocytes have also been found to synthesize 
and secrete antimicrobial peptides and signal to other organs, such as the larval fat 
body, in response to an infection [49,52,53].  
 
4. Cellular Antiviral Innate Immune Mechanisms in Insect Vectors 
Unlike mammalian hosts, insect vectors rely exclusively on innate defenses for 
antiviral immunity. At the molecular level, several viral recognition and antiviral signaling 
pathways have been identified in insects. Many of these pathways have proven to be 
ancient and highly conserved, also playing fundamental roles in the innate defenses of 
vertebrate hosts. Pattern recognition receptors (PRRs) sense pathogen-associated 
molecular patterns (PAMPs), leading to the activation of antimicrobial host signaling 
programs [54,55]. These receptors recognize conserved components of different 
pathogens, including viral nucleic acids and viral glycoproteins [54,56]. There are distinct 
classes of PRRs that either act as membrane-bound or cytoplasmic sensors, including 
transmembrane proteins such as the mammalian Toll-like receptors (TLRs) and C-type 
lectin receptors (CLRs), as well as cytoplasmic proteins such as the Retinoic acid-
inducible gene (RIG)-I-like receptors (RLRs) and NOD-like receptors (NLRs) [54]. In 
mammals, the sensing of PAMPs by PRRs induces the transcriptional activation of many 
genes, although the expression patterns of these inducible genes differ among activated 
PRRs [54,57,58]. These genes can encode proinflammatory cytokines, type I interferons 
(IFNs), chemokines and antimicrobial proteins, proteins involved in the modulation of 
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PRR signaling, and many uncharacterized factors [54,57,59]. It is important to note that 
while innate immune responses to viruses in mammals rely heavily on the interferon 
response, insects do not seemingly encode such a pathway. While the PAMPs and 
PRRs that drive antibacterial and antifungal gene expression programs have been 
characterized in insects, less is known about antiviral defenses. 
The Toll Pathway 
The Toll receptor was discovered in the model insect Drosophila and led to the 
subsequent discovery of mammalian Toll-Like Receptors (TLRs) [29,60,61]. Research 
has revealed that signaling pathways downstream of Toll and TLRs are highly 
conserved, both of which converge on the induction of NFκB-dependent genes (Figure 
6). In insects, many studies have implicated this pathway in antibacterial and antifungal 
defense [30,31]. However, the Toll pathway has also been found to protect against some 
viral infections. For example, it has been found to be both systemically induced by and 
restrict Dengue infection in Aedes mosquitoes [62,63]. However, the canonical NFκB-
dependent genes of the insect Toll pathway are not induced by viral infection. The 
antibacterial and antifungal genes have also not been found to have antiviral activity. 
Therefore, it is likely that the Toll pathway confers antiviral activity through non-classical 
means, an area that remains to be understood. Consistent with this hypothesis, it was 
recently shown that Toll-7 in Drosophila activates the antiviral cellular process of 
autophagy upon sensing VSV glycoproteins, which is independent of NFκB [64]. 
The IMD Pathway 
A second PRR pathway that has been well characterized in insects, including 
Drosophila and Aedes mosquitoes, is the IMD pathway. This pathway shares homology 
with the tumor necrosis factor pathway in mammals and converges on different NFκB 
transcription factors to induce a distinct antimicrobial transcriptional program (Figure 4). 
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IMD signaling is canonically thought to restrict Gram-negative bacteria [65-68]. In 
addition to clear roles in the fat body in this context, studies have demonstrated that the 
IMD pathway plays an important antibacterial role in the insect digestive tract [32,69,70]. 
Recent studies suggest that the IMD pathway also controls Sindbis virus and Cricket 
paralysis virus infection at the organismal level [71,72]. It is important to note that the 
tissue types conferring IMD-mediated protection to these viruses remain incompletely 
characterized [71,72].  Furthermore, it remains unclear how IMD signaling 
mechanistically confers antiviral protection, as the canonical antimicrobial peptides 
downstream of this pathway are not induced by viral infection [71,72]. 
Transcriptional Regulation 
  In insects, bacterial or fungal challenge leads to the rapid induction of disparate 
antimicrobial effectors, depending on whether the Toll or IMD signaling pathway is 
engaged (Figure 6). For these types of infections, the massive expression of novel 
peptides and polypeptides that occurs is primarily regulated at the level of transcription 
initiation [73]. The cloning in the early 1990s of the genes in Drosophila that encode 
antimicrobial peptides (AMPs), followed by promoter mapping experiments with the 
Cecropin A1 and Diptericin genes, revealed the presence of DNA motifs required for 
immune inducibility [74-77]. These include a combination of NFκB binding sites, GATA 
binding sites recognized by the transcription factor Serpent, and a less well-defined motif 
called R1 [77-79], all of which help recruit RNA Polymerase II to initiate transcription. 
Prominent among these motifs are the κB response elements, which confer immune 
inducibility [79,80]. In addition, three NFκB/Rel-like proteins are encoded in the 
Drosophila genome: Dorsal and Dif are downstream of Toll signaling, whereas Relish is 
downstream of the IMD pathway [81-84]. Genetic studies have demonstrated the key 
roles of these transactivators in the regulation of AMPs.  
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JAK/STAT pathway 
JAK/STAT signaling is a canonical mammalian antiviral signaling pathway and is 
an important component of the interferon response [85]. While interferon activity has not 
been demonstrated in insects, the JAK/STAT signaling pathway has been found to have 
antiviral activity in insects, including Drosophila, Aedes, and Culex [86-88]. As in 
mammals, the Drosophila and mosquito JAK/STAT signaling cascade also restricts 
arboviral infection [86-88], likely through an induced transcriptional program that has yet 
to be fully characterized. A recent study identified a JAK/STAT-dependent antiviral 
expression program that is active against Dengue virus in Aedes [72]. Two of these 
genes, DVFR1 and DVFR2, have demonstrated antiviral properties [87]. However, 
whether these JAK/STAT responsive genes are sufficient to explain the antiviral activity, 
or if other effectors are involved, remains unclear. In Drosophila, the JAK/STAT pathway 
is induced in bystander cells [88], not the infected cells, which lead to the question of 
how viruses are sensed to activate this pathway. Furthermore, the kinetics of gene 
induction are slow by JAK/STAT signaling [88], leading to the question of whether there 
are also rapidly activated programs that restrict viral infection in insects. 
MAPK Signaling pathways 
There are three ancient and highly conserved MAPK pathways in organisms from 
yeast to humans: ERK, JNK, and p38 [89,90]. These signal transduction pathways are 
ubiquitous and highly evolutionarily conserved, which enables coordinated and 
integrated responses for a diverse range of stimuli [91,92]. The three-tiered “core 
signaling module” is one of the defining features of MAPK pathways [93]. An extremely 
diverse group of protein kinase families, known as MAPK kinase kinases (MAP3Ks), first 
become activated via phosphorylation in response to stimuli [93]. Subsequently, these 
kinases phosphorylate and activate dual-specificity MAPK kinases (MAP2Ks) [93]. 
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Lastly, MAPKs become phosphorylated and activated within an evolutionarily conserved 
Thr-X-Tyr motif in its activation loop [89,93]. MAPK core signaling modules are 
themselves regulated by a poorly understood array of upstream components. These 
pathways can be triggered by hormones, growth factors, environmental stressors, and 
even PAMPs that recruit vertebrate PRRs [91,92,94]. MAPK pathways, once activated, 
exert various effects on the cell, including activating specific transcription factors to 
facilitate gene expression [95,96]. 
ERK signaling is best characterized for its role in growth and development 
[97,98]. Indeed, many tumors have disregulation or over activation of this pathway in 
humans [99-101]. In Drosophila, upstream receptors include the Insulin Receptor (InR), 
Epidermal Growth Factor receptor (EGFR), and PDGF- and VEGF-receptor related 
(PVR) receptor [102]. These receptors can be found in various tissue compartments 
throughout the insect life cycle and generally promotes cell division and growth [91]. 
Over activation of components in the ERK pathway in Drosophila, such as Ras, can also 
lead to tumor formation [103-105]. There is currently little known about the potential 
immunologic roles of ERK signaling in insects. Recent studies have found that the 
pathway is a negative regulator of the antibacterial IMD pathway [69], but its role(s) in 
viral infection remain uncharacterized. 
The JNK pathway regulates many developmental processes in Drosophila and is 
required for proper wound healing of the epidermis [106,107]. Microarray analysis of S2 
cells, a hemocyte-derived cell line, indicates that engaging the IMD pathway can also 
subsequently activate JNK signaling in response to bacterial infection [108,109]. In these 
cells, JNK-dependent gene expression reveals many proteins involved in cytoskeleton 
remodeling are induced [108,109]. At the organismal level, a role for the JNK pathway in 
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antimicrobial gene expression by the fat body has also been proposed [108,110]. 
However, a role for JNK signaling in viral infection has not yet been characterized.  
The p38 stress pathway has been implicated in the immune response of plants, 
Caenorhabditis elegans, and mammals [96,111,112]. The Drosophila genome encodes 
two homologs of p38, and cell culture experiments identified several MAPKs acting 
upstream [113,114]. The p38 MAPK pathway is evolutionarily conserved in stress 
responses [114], but its role in insect host defense is not fully understood. p38 mutant 
flies have been found to exhibit immunodefneciency, as they have hindgut melanization 
and larvae stage lethality induced by microbes naturally presented in food [115]. 
However, neither Toll nor IMD is required for this microbe-induced p38 activation 
[115,116]. Furthermore, the role of p38 in antiviral immunity has also not yet been 
determined.	  	  
 
Antiviral Effector Mechanisms 
Autophagy 
The cellular process of autophagy, a cell-intrinsic mechanism that is typically 
activated upon starvation to degrade and recycle cytoplasmic contents, has been found 
to restrict viral infection in insects. In a search for cell-autonomous pathways that directly 
inhibit viral infection, our lab identified an antiviral role for autophagy against VSV in 
Drosophila via a Toll receptor, Toll-7 [64]. Upon infection of either cells or flies, we found 
that autophagy is activated and restricts viral replication [117]. This program is activated 
via the attenuation of the PI3K/Akt pathway that normally controls autophagy in 
response to nutrient signaling [117]. Importantly, the PAMP was identified as the viral 
glycoprotein [117]. The inhibition of nutrient signaling may play two roles during infection. 
First, our data suggest that this inhibition leads to the activation of autophagy. Second, 
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as we have recently showed, that attenuation of Akt signaling allows for the reallocation 
of resources from growth to immune defense against bacterial and fungal pathogens 
[117]. Activation of the Toll pathway via infection with these microbes led to the 
repression of Akt signaling and the inhibition of fat storage [118]. Whether or not the 
reallocation from nutrient storage to innate immune defense is also essential to combat 
viral infection has yet to be elucidated. 
RNA interference  
In insects, RNA interference (RNAi) consists of three small RNA-dependent 
silencing pathways that regulate gene expression in a sequence-specific manner [56]. 
RNA silencing not only regulates endogenous gene expression, but also regulates 
exogenous sources of RNA, including viral RNAs [119]. In contrast, mammals have only 
maintained RNA silencing pathways to control endogenous gene expression. Instead of 
antiviral RNA silencing mechanisms, it is thought that mammals evolved the interferon 
response. Interestingly, both pathways can be triggered by viral dsRNA, suggesting that 
these organisms converged on this viral PAMP for immune recognition.  
In insects, the RNaseIII-like enzyme Dicer generates a 21-23nt RNA duplex 
(siRNA) from a larger dsRNA precursor molecule, including viral dsRNA replication 
intermediates and highly structured viral RNA molecules [120]. SiRNA is then 
incorporated into the RNA-induced silencing complex (RISC), which is a complex that 
retains one of the RNA strands and helps guide RISC to cleave the complimentary 
sequence on the viral RNA target [121]. Mutants in the core siRNA machinery (Dcr-2, 
r2d2, and AGO2) display increased sensitivity to infection by several RNA viruses, 
including Flock House virus (FHV), Drosophila C virus (DCV), cricket paralysis virus 
(CrPV), Sindbis virus (SINV), vesicular stomatitis virus (VSV), Drosophila X virus (DXV), 
West Nile virus (WNV), and Rift Valley Fever virus (RVFV) [119,121-123] (Sabin, Cherry, 
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unpublished results). In addition, studies of mosquito vectors have demonstrated that the 
RNAi pathway restricts arboviruses including O’nyong-nyong virus, SINV, WNV, and 
Dengue virus [119,122,124-126]. 
While Dcr-2 clearly plays an antiviral role through the RNA silencing pathway, 
recent evidence also suggests that Dcr-2 may also trigger a downstream antiviral 
signaling cascade upon binding and recognition of viral dsRNA [127]. Dcr-2 belongs to 
the DExD/H-box helicase family, and is the closest insect ortholog to the mammalian 
RIG-I-like receptors, which sense and respond to cytoplasmic viral RNA. Engagement of 
viral RNA by Dcr-2 both leads to antiviral silencing and initiates a specific transcriptional 
response, including the induction of Vago, an antiviral effector both in Drosophila and 
mosquitoes [86,127]. Although the full spectrum of genes induced by Dcr-2 is unknown, 
these data suggest that this insect cytoplasmic sensor can generate complex responses 
to viral replication, which may be more analogous to mammalian innate responses than 
previously imagined. 
 
5. Drosophila melanogaster as a model organism for antiviral innate immunity 
Our knowledge of the underlying antiviral innate immune mechanisms that 
protect disease-transmitting insect vectors is incomplete. This is due in part to the 
difficult nature of performing molecular and genetic studies using insect vectors, 
including hematophagous mosquitoes. Drosophila offers several advantages as a model 
insect for identifying and studying antiviral mechanisms that are unique to insect vectors 
[128,129], Drosophila shares a high degree of conservation with these organisms, 
exhibiting similar metamorphic life cycles and genetic pathways [128,129]. This has 
historically allowed researchers to take advantage of powerful Drosophila genetic tools 
to improve our understanding of insect antiviral immunity [29]. Many viral restriction 
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pathways, including RNA interference and JAK-STAT signaling, have been 
characterized using this model and shown to be conserved in insect vectors [56,130]. 
Hence, Drosophila can be a very useful tool for discovering novel antiviral restriction 
mechanisms in insect vectors. 
 More than twenty diverse groups of viruses can infect insects, many of which 
also infect humans or serve as models for human-related pathogens [4,131]. These 
pathogens have evolved diverse replication strategies, tropism, and pathogenicity. 
Characterizing the spectrum of unique and common antiviral restriction mechanisms 
may also help in the development of a wide variety of targeted therapies and control 
strategies. Furthermore, we and others have shown that many diverse human 
arboviruses can infect Drosophila, including RFV, Dengue, Sindbis, and West Nile virus 
[56,132,133]. Importantly, where explored, the same innate restriction mechanisms 
identified in Drosophila also play similar roles in insect vectors, making this a useful 
system for investigation. 
Drosophila also has conserved developmental and cell biological processes with 
vertebrate hosts, making it an even more valuable and unique model for study. Many of 
the classic signal transduction systems were first identified in Drosophila using forward 
genetic screens and subsequently found to be conserved in mammalian hosts [134,135]. 
As illustrated by studies of Toll, Drosophila has proven to be a useful model system to 
identify shared restriction mechanisms [61,136,137]. Given Drosophila’s extensive 
conservation with both insect vectors and mammalian hosts, this model organism also 
offers unique opportunities for understanding anciently evolved and common 
mechanisms. 
Tools to identify novel antiviral mechanisms in vitro 
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Drosophila has historically been used as a genetic model system and has led to 
the development of an array of tools to perform genetic screens. This has been 
complemented by the completion of the Drosophila genomic sequence in 2000 and the 
subsequent expansion of new post-genomic technologies including proteomics, 
microarrays, and RNAi (RNA interference) [138,139]. RNA interference is gene-specific 
loss-of-function approach, which takes advantage of the specific targeting and 
destruction of mRNA by the RISC complex, thereby depleting transcripts for any gene of 
interest [140,141]. Since the Drosophila genome is compact and has low redundancy, 
single gene mutants are more likely to reveal phenotypes of interest, in contrast to 
mammals where redundant gene families can make similar analyses more complex 
[140,142]. RNAi in Drosophila cells is also relatively efficient and straightforward, and 
thus has been extensively used to study many aspects of biology that can be modeled in 
cells in vitro [140,143]. In our lab, each step in the process has been carefully selected 
and optimized for a variety of viral pathogens that can infect Drosophila cells in a 384-
well format, which allows for high-throughput screening (Figure 4) [142]. Different 
libraries can be used to dissect host factor requirements, ranging from focused gene 
sets to genome-wide libraries. Knockdown of a given gene can either decrease or 
increase the read-out in question, and potential candidates can be identified using 
statistical cut-offs [142]. Secondary assays are used to more fully characterize the role of 
the identified candidates in the biological process under study [142].  
The disparate Drosophila cell lines derived from a variety of cell types also allow 
us to probe for tissue-specific responses. For example, hemocyte-derived cells such as 
Schneider line 2 (S2) cells as well as Kc167 cells are responsive to Pattern-Associated-
Molecular-Patterns (PAMP) and can be used to elucidate this aspect of immunity [143]. 
Furthermore, the highly phagocytic nature of these cells can be used to understand 
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pathogen uptake and clearance [50]. Given that specific arboviral tropisms remains 
poorly understood, surveying disparate cell lines for infectivity also allows us to 
characterize arboviral tropism and to subsequently understand viral entry pathways 
[144]. 
Altogether, our lab and others have successfully applied this RNAi-based 
screening in Drosophila cells to the study of host factors that impact viral infection 
(Figure 4). This had led to the discovery of both virus-specific and broadly antiviral 
factors. For instance, RNAi screening against disparate RNA viruses led to the discovery 
of a novel antiviral factor Ars2, which is an RNA binding protein that restricts RNA 
viruses, including the arboviruses Sindbis (SINV) and Vesicular Stomatitis Virus (VSV), 
in Drosophila [122]. In addition, a genome-wide screen against SINV has led to the 
discovery of its receptor, the iron-binding transmembrane receptor called NRAMP, which 
we found to be the receptor in both insects and mammals [144]. 
Tools to dissect antiviral mechanisms in vivo  
The rapid Drosophila life cycle in combination with its wide array of genetic tools 
also allows for efficient investigation of arboviral-host interactions in vivo 
[128,129,145]. The wealth of genetic mutants readily obtainable from stock centers 
alone (e.g., two genome-wide in vivo RNAi transgenics screening available) allows for 
systematic investigation of antiviral factors at the organismal level [138,146,147]. 
Genetic manipulations using conditional drivers allow for more detailed virus-host 
interaction studies in vivo [97,145]. For example, the Gal4/UAS system is used to drive 
the expression of UAS-inverted repeat transgenes that bear long hairpin dsRNA 
constructs to target the endogenous transcripts in vivo (Figure 5) [146,147]. One can 
also use the same system to ectopically express cDNAs using transgenes. To bypass 
developmental requirements, we can take advantage of conditional drivers or tissue-
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specific promoters to manipulate factors-of-interest within specific cell types or tissues, in 
addition to providing a temporal on/off switch [53,145,148]. Using Drosophila genetics, 
we can trace the lineage of dividing cells and study its descendants in the context of an 
infection [53,148,149]. In summary, there are many in vivo tools that allow us to probe 
antiviral pathways at the organismal level. 
Furthermore, our lab and others have also developed methods to infect 
Drosophila with a wide variety of viruses successfully, including representative members 
of each family of human arboviruses. These include Sindbis virus, Rift Valley Fever 
virus, and Kunjin virus. Other viruses with varying structural and pathogenic properties, 
including vesicular stomatitis virus, and natural Drosophila pathogens can also be used 
in virus-host studies [56,117]. A variety of assays can be used to monitor viral replication 
and pathogenesis in vivo, including survival studies as well as molecular assays to 
monitor viral protein, viral RNA, or levels of infectious particles that are produced during 
the course of an infection [56,117]. In addition, microscopy can be used to monitor the 
infection of individual cells in disparate tissues, including the fat body. By comparing and 
contrasting arboviral pathogens, we hope to identify both general and virus-specific 
innate restriction mechanisms.  
 
6. Aims of the Present Studies 
Virus-host interactions are a delicate interplay of opposing forces: the virus 
attempts to subvert cellular machinery to aid in its replication while the host mounts an 
immune response to eliminate the infection. The goal of this thesis is to take advantage 
of the powerful genetic tools in Drosophila to identify novel cell-intrinsic innate immune 
pathways that restrict arboviral infections, thereby contributing to our knowledge of virus-
host interactions for pathogens that cause emerging infectious illnesses.  
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By performing a cell-based RNAi screen against a panel of disparate 
arboviruses, we identified broadly antiviral candidates for further investigation. In 
Chapter 3, we explore the role of two of these genes belong to the NELF complex, called 
NELF-B and NELF-D, which led us to discover a novel antiviral transcriptional gene 
program that is activated during early infection. Innate immune responses are 
characterized by precise gene expression, whereby gene subsets are temporally 
induced to limit infection. The current paradigm for orchestrating such innate immune 
responses is at the step of transcription initiation. Controlling innate response genes at 
alternate steps in the transcription cycle has not been well explored. We found that 
antiviral immunity in Drosophila requires an alternate gene regulatory mechanism, called 
transcriptional pausing. Depletion of components of this pathway, including negative 
elongation factor (NELF) that pauses RNA polymerase II (Pol II) and positive elongation 
factor b (P-TEFb), which releases paused Pol II to produce full-length transcripts, 
resulted in increased viral infection in Drosophila cells. This led us to identify a set of 
genes that is rapidly transcribed upon arbovirus infection, including components of 
antiviral pathways (RNA silencing, autophagy, JAK/STAT, Toll, and IMD) and various 
Toll receptors. Many of these genes require P-TEFb for expression and exhibit pausing-
associated chromatin features. Furthermore, transcriptional pausing is critical for antiviral 
immunity in insects, since NELF and P-TEFb are required to restrict viral replication in 
adult flies and vector mosquito cells. Thus, transcriptional pausing primes virally induced 
genes to facilitate rapid gene induction and robust antiviral immunity. 
In Chapter 4, we explored a subset of genes that are transcriptionally induced 
during early viral infection, which led us to discover that the ERK pathway is involved in 
antiviral defenses of disparate insects. A unique facet of arthropod-borne virus 
(arbovirus) infection is that an insect vector orally acquires these pathogens during the 
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taking of a blood meal. Hence, there is a direct link between nutrient acquisition and 
pathogen challenge. A coupling of this nutrient rich signal with host defense would likely 
benefit the organism. We found that the nutrient responsive ERK pathway is both 
induced by and restricts disparate viral infections, including human arboviruses, in 
Drosophila and mosquito cells. Furthermore, ERK signaling is essential for antiviral 
defense in the insect intestinal epithelium. While wild type flies are refractory to oral 
infection by arboviruses including Sindbis virus (SINV) and Vesicular Stomatitis virus 
(VSV), this innate restriction can be overcome chemically by oral administration of an 
ERK pathway inhibitor or genetically via the specific loss of ERK in the intestinal 
epithelial cells. Either treatment results in robust viral infection of the gut. Furthermore, 
vertebrate insulin that activates ERK signaling in the mosquito gut during a blood meal 
[150] can both restrict viral infection in insect cells and protect against viral invasion of 
the gut epithelium. These studies collectively demonstrate that ERK signaling in the 
insect intestines potently restricts viral infection, suggesting that insects take advantage 
of signals in the meal to preemptively activate antiviral immunity. 
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Figure 1. Probable temporal sequence and dispersal routes of WNV from its 
proposed center of origin in sub-Saharan Africa [1,151]. WNV is distributed 
circumglobally, with two main genetic lineages: Lineage 1 is widely distributed and highly 
invasive, whereas Lineage 2 remains in Africa. Sub clades of Lineage 1 are widespread 
throughout Africa and the Mediterranean: Lineage 1b (aka Kunjin virus) is restricted to 
Australia and Lineage 1c is found in Central Asia through the central highlands of India. 
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Figure 2. Global distribution of Dengue Virus infection in 2012.  Blue regions 
represent areas of ongoing transmission risk as defined by the Centers for Disease 
Control and Prevention (CDC). Red markers indicate recent reports of local and regional 
Dengue or imported cases of Dengue. 
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Figure 3. Generalized Arboviral Transmission Cycle.  Arboviral infection alternates 
between vertebrate reservoirs and arthropod vectors. The insect will bite the vertebrate 
host and infect it, and then later, another insect will bite that same host, contract the 
infection, and continue to spread it to other vertebrate hosts. This type of life cycle 
comes to a dead end if an insect carries the infection to a human or animal; once there, 
the infection stops reproducing and does not re-transmit to a new host.  
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Figure 4. General workflow for arrayed cell-based RNAi screening. In brief, 
Drosophila cells are plated in a 384-well format with spotted dsRNA. The cells are 
incubated for 3 days to allow for efficient depletion of the genes-of-interest. Then, cells 
are infected with virus. Immunofluorescence and automated microscopy are performed 
to measure the percentage of infected cells. Statistical analysis is used to identify viral 
permissivity and restriction factors. 
	    
Array-based RNAi screening in Drosophila cells 
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Figure 5. The heat shock-inducible UAS/Gal4 system for In vivo RNAi in 
Drosophila. In F1 progeny, heat shock at 37°C will induce the expression of Gal4, which 
binds to the UAS element to activate the synthesis of the inverted repeat sequence. The 
inverted repeat forms a snapback that is processed by the RNAi machinery to deplete 
the gene-of-interest.  
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Figure 6. Antiviral pathways in Drosophila.2 This figure highlights the major antiviral 
pathways in insects: Toll, IMD, JAK/STAT, autophagy, and RNA interference pathways.  
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2 Adapted from Sabin LR, Hanna SL, Cherry S. Innate Immunity in Drosophila. Curr Opin 
Immunol. 2010 Feb;22(1):4-9. 
	  27	  
CHAPTER 2. Materials and Methods 
 
1. Cells and Cell Culture  
Drosophila DL1 and S2 cells were grown and maintained at 25°C in Schneider’s 
Drosophila medium (containing 10% FBS, GlutaMAX and penicillin/streptomycin). Aedes 
albopictus C6/36 cells were grown in a non-CO2-equilibrated environment and were 
maintained at 25°C in L-15 medium (containing 10% FBS, GlutaMAX and 
penicillin/streptomycin). Aedes aegypti Aag2 cells were grown and maintained at 25°C in 
in Schneider’s Drosophila medium (containing 10% FBS, GlutaMAX and 
penicillin/streptomycin). U2OS cells were grown in DMEM (containing 10% FBS, 
GlutaMAX and penicillin/streptomycin). Passaging of C6/36, Aag2, and mammalian cells 
required trypsinization. Cell culture materials are from Gibco. 
  
2. Viruses 
VSV-eGFP (gift from J. Rose) was grown in BHK cells as described (112). Sindbis/GFP 
(gift from R. Hardy) was grown in C636 cells (15). Kunjin virus (gift from M. Diamond) 
was propagated in BHK cells, concentrated using Centricon Plus-70 (Millipore), and 
ultracentrifugation through a sucrose cushion as described previously [152]. RVFV strain 
MP12 was grown in Vero-E6 cells and concentrated through a Centricon Plus-70 filter as 
described [153]. DCV was grown as described [154].  
 
3. Antibodies 
Antibodies were obtained from the following sources: rabbit anti-GFP (Invitrogen), 
mouse anti-tubulin (Sigma), chicken anti-DCV (24), anti-WNV NS1 (9NS1 - gift from M. 
Diamond) that cross reacts with KUN, anti-RVFV N (1D8 – gift from C. Schmaljohn), and 
anti-DCV [154], mouse RNA Pol II (CTD4H8) (Millipore), rabbit phospho- and total ERK 
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antibodies (Cell signaling). Fluorescently labeled secondary antibodies were obtained 
from Jackson Immunochemicals, and HRP-conjugated antibodies from Amersham.  
 
4. dsRNA Synthesis 
SnapDragon design tool (flyRNAi.org) was used in dsRNA design for RNAi with the 
following criteria: (1) ~500nt region within an exon in the gene of interest and (2) zero 
predicted off-targets, defined as sequences 19bp or longer with perfect complementarity 
to another site in the Drosophila genome. Forward and reverse primers containing the 
T7 RNA polymerase promoter sequence TAATACGACTCACTATAGG were designed to 
amplify the region of interest. Two rounds of PCR were performed using Drosophila 
genomic DNA as the original template. PCR products were then used as templates for in 
vitro transcription using the MEGAScript T7 kit (Ambion) as per manufacturer’s 
instructions. dsRNA was purified using an RNeasy kit (Qiagen) following the 
manufacturer’s protocol. 
 
5. RNAi 
Cells were passaged into serum free media (SFM) and plated into wells containing 
dsRNA at 250ng/16,500 cells for 384 well plates, 750ng/50,000 cells for 96 well plates, 
and 4ug/2.5x106 cells for 6 well plates. After 1 hour in SFM, complete media was added 
and cells were incubated at 25°C for three days to allow for gene knockdown. 
 
6. Viral Infections for Cell Culture Experiments 
Three days post-dsRNA bathing, cells were infected with the indicated viral inoculum. 
VSV, SINV, DCV, RFV , or KUN inocula were added to the existing media in 384 well 
plates in 10µL of serum-free Schneider’s media. Cells were fixed at 24 hours post 
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infection. SINV, RFV and KUN were spinoculated as follows: existing media was 
removed, virus inoculum was added to wells in 10µL of serum-free Schneider’s media, 
cells were spun at 1200 rpm for 2 hours, then 20µL of 10% serum Schneider’s media 
was added to cells. SINV-infected cells were fixed at 36 hours post-infection. For 
infections of 6 well plates, viral inocula were added directly to the existing media and the 
cells were collected and processed at 24 hours post-infection. U0126 was obtained from 
Cell Signaling. 
 
7. Immunofluorescence 
Cells were fixed for 10 minutes in 4% formaldehyde, washed in PBS/0.1% TritonX-100 
(PBST) twice for 10 minutes each, and blocked in 2% BSA/PBST for 30 minutes. 
Primary antibody was diluted in block and incubated with cells overnight at 4°C. Cells 
were washed three times in PBST, and incubated in secondary antibody for one hour at 
room temperature. Cells were counterstained with Hoescht33342 (Sigma). Following 
secondary antibody staining and counterstaining, cells were washed an additional three 
times in PBST and imaged using an automated microscope (ImageXpress Micro). 
Images of three sites per well were collected and with a minimum of three wells per 
treatment. Automated image analysis was performed using MetaXpress image analysis 
software and percent infection was measured for each image. For fly guts, they were 
dissected and processed as previously described [155]. Coverslips were mounted and 
imaged using 20X and 40X objectives with a Leica DMI 4000 B fluorescent microscope. 
 
8. Immunoblotting 
Cells, 5 flies, or 15 fly guts were collected and lysed in radioimmunoprecipitation (RIPA) 
buffer 
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(50mM Tris, 150mM NaCl, 0.5% Na-Deoxycholate, 0.1% SDS, 1% NP-40) 
supplemented with 1mM PMSF and a complete protease inhibitor cocktail (Roche). 
Following a 10 minute incubation on ice, lysates were cleared by centrifugation for 10 
minutes at 4°C. 20-50 µg of total protein was separated on a denaturing 10% or 12% 
SDS-PAGE gel and transferred to a PVDF membrane (Millipore). Blots were incubated 
in block (5% milk in TBST) for 30 minutes at room temperature, probed overnight at 4°C 
with the indicated primary antibody. Blots were washed twice for 5 seconds each with 
water, then probed 1 hour at room temperature with the indicated HRP-conjugated 
secondary antibody diluted in block. Blots were washed twice for 5 seconds each with 
water, incubated 5 minutes in TBST, then washed six times for 5 seconds each with 
water. Blots were then incubated with ECL reagents (Perkin Elmer) and exposed to film. 
For phospho-Erk studies in cells, infections were synchronized by pre-binding virus at 
16°C for one hour, then brought to 25°C and processed at the indicated time points. 
 
9. Adult Fly Infections 
Flies carrying UAS-NELF-B IR and UAS-Cdk9 IR were obtained from the Vienna 
Drosophila RNAi Center. Flies carrying UAS-NELF-B IR, UAS-Cdk9 IR, or control (wild-
type or UAS-lacZ IR) were crossed to hs-Gal4 at room temperature. Three- to six-day-
old adults of the stated genotypes were infected as previously described [117,144]. On 
the day of injection, the hs>control, hs>UAS-NELF-B IR, hs>UAS-CDK9 IR progeny 
were heat shocked at 37°C for 1 hour, challenged, and heat shocked every 2 days 
throughout the experiment. Flies were processed for plaque assays on BHK21 cells at 
the indicated time points post-infection and for Northern blots, as previously described 
[117]. For feeding experiments, seven- to ten-day-old adult female flies were used. Wild 
type (w1118) flies were used for drug studies. Myo1A-Gal4 was obtained from E. 
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Baehrecke and UAS-Erk IR (#109108) was obtained from the VDRC. Prior to the day of 
infection, flies were restricted to a water-only diet for 12 hours and starved for 30 
minutes prior to feeding for synchronizing ingestion. The food contained 5% sucrose 
plus dye in addition to the indicated treatment. Flies were processed at the indicated 
times post-treatment as described [132]. 
 
10. RNA, Northern Blotting and RT-qPCR 
Total RNA was extracted from cells or flies using Trizol (Invitrogen). 10ug total RNA was 
separated on a 1% agarose/formaldehyde gel prepared in MOPS buffer (2mM MOPS, 
50mM NaOAc, 10mM EDTA, pH7.0). Gel was washed twice for 10 minutes in water, 
transferred to a Hybond N+ membrane (Amersham) overnight at room temperature. 
Blots were UV-crosslinked and pre-hybridized in Church buffer (0.5M NaPO4, 7% SDS, 
1mM EDTA) for 30 minutes, then probed overnight at 65°C with internally radiolabeled 
PCR probes complementary to the transcript of interest. PCR products were internally 
labeled using a Prime-It II Random Primer Labeling kit (Stratagene) in the presence of 
[α-32P]dCTP, and purified over a MicroSpin G-50 column (Amersham). Blots were 
washed twice for 15 minutes each using 2x SSC / 0.1% SDS, then once for 15 minutes 
each using 0.2x SSC/0.2% SDS. Blots were exposed to a phosphoimager cassette and 
imaged using a Typhoon imager (GE Healthcare). Samples were normalized against 
controls using ImageQuant software (Amersham). For RT-qPCR, cDNA was prepared 
from total RNA using M-MLV reverse transcriptase (Invitrogen) and random primers. 
cDNA was analyzed using Power SYBR Green PCR Master Mix (Applied Biosystems) 
along with gene specific primers in duplicate, for three independent experiments. Data 
was analyzed by relative quantification, by normalizing to Rp49. qPCR primers for 
Diptericin B and Attacin B were used as previously described [156]. Unless otherwise 
	  32	  
indicated, data is represented as relative mRNA expression compared to the untreated 
samples and displayed as the mean ± SD for three independent experiments. 
 
11. Chromatin-Immunoprecipitation (ChIP) 
ChIPs were performed based on [157]. The Magna ChIP kit (Millipore) was used with the 
following specifications: 10 million Drosophila cells were formaldehyde cross-linked for 
10 minutes at room temperature and lysates were sonicated for 20 cycles of 30s ON 60s 
OFF to generate <500 bp DNA fragments using the Branson Sonifier 250 at power 2. 1 
ug of Mouse anti-RNA Pol II CTD4H8 antibody was used per IP. qPCR was performed 
as described above. The data is represented as a percentage of each input and 
displayed as the mean ± SD for three independent experiments. 
 
12. DNA Microarray Analysis 
For expression profiling on Affymetrix Drosophila GeneChip microarrays (Affymetrix), 
Drosophila cells were treated with Bgal or Cdk9 and either treated as uninfected or 
infected with VSV (MOI 10) for 4 hours, in two independent biological replicates. Total 
RNA was isolated using Trizol and microarray experiments were performed at the 
University of Pennsylvania Microarray Facility (U. Penn MF) following directions 
according to the manufacturer’s protocol (Affymetrix). In brief, brief, 100 ng RNA were 
amplified with the Ovation RNA Amplification System v2 (NuGen), the Encore Biotin 
Module (NuGen) was used for fragmentation and labeling, Protocol FS450 002 was 
used for hybridization, washing, and staining. Images were scanned using the 
GeneChip® Scanner 3000 and image analysis was performed using the Affymetrix® 
GeneChip® Command Console® Software (AGCC). Arrays were analyzed using the 
Affy [158] and limma packages [159] for R [R: Development core team (2004). R: A 
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language and environment for statistical computing. R foundation for statistical 
computing. Vienna, Austria. http://www.r-project.org ] and Microsoft Excel. We calculated 
fold changes relative to uninfected controls and considered significant genes with at 
least a 2.8 fold change. For Cdk9-dependence, we calculated fold changes relative to 
VSV-infected samples and considered significant genes with ≥1.5 fold down-regulation. 
For hierarchical clustering and visualization, MeV software was used. The web-based 
application Expression Analysis Systematic Explorer (EASE) [160], part of the Database 
for Annotation, Visualization and Integrated Discovery (DAVID) [161], was used to 
identify overrepresented gene ontology terms within a given list of genes (3-22 genes 
per category, p<0.05) (http://david.abcc.ncifcrf.gov/home.jsp). The GEO accession 
numbers for the microarrays are GSE41146 and GSE41242. 
 
13. Bioinformatics and Statistics 
We mapped the Drosophila ChIP-on-chip data for total Pol II (Rpb3), NELF-B, and Spt5 
[162], H3K4me3 [163], and the short RNA sequence reads [164]. For H3K4me3 ChIP-
seq data, the processed data files were directly utilized [163]. For 5’ short RNA 
sequence reads, raw sequences were aligned using the RNA-sequence alignment 
pipeline at http://www.cbil.upenn.edu/RUM/ (G.G, unpublished). To determine the 
percentage of genome-wide and VSV-induced (P-TEFb-dependent) Drosophila genes 
with pausing-associated chromatin features, we analyzed 12,009 probes that contained 
Flybase IDs from the Drosophila GeneChip microarrays that have at least 3 of 4 pausing 
criteria as described. We mapped the ChIP-on-chip data for total Pol II in Kc167 and 
CME W1 cl.8+ cells from ModEncode [165]. Chi-squared tests were performed to 
determine statistical significance. For other experiments, the Student’s two-tailed t-test 
was used to measure the statistical significance for three independent experiments. For 
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qPCR studies, p-values were obtained by comparing delta CT values for three 
independent experiments. 
 
14. Oligonucleotide Sequences for RT-qPCR 
 
Rp49 Forward 5’ – AAGAAGCGCACCAAGCACTTCATC – 3’ 
Rp49 Reverse 5’ – TCTGTTGTCGATACCCTTGGGCTT – 3’ 
PGRP-SA Forward 5’ – ACAAAGAACGCGGAGATTTGCGAC – 3’ 
PGRP-SA Reverse 5’ – AATCGAACCGGCTGCATGATGTTG – 3’ 
Nos Forward 5’ – TGGCGGAGTGGTCAGATCAAAGAA – 3’ 
Nos Reverse 5’ – ACTGCTAAATCGACTGGTGGGTGT – 3’ 
Tep II Forward 5’ – TGACGTCGATGGAAAGGGTCATGT – 3’ 
Tep II Reverse 5’ – AACAACTGTGGCAGTGGCATTCTG – 3’ 
Tl Forward 5’ – TGCGTGCAGTGAGATGAGCATAGA – 3’ 
Tl Reverse 5’ – TGATCTGCACGTAGTCTTTGGGCT – 3’ 
Toll-2 Forward 5’ – TAATACGACTCACTATAGGTGCTGACCTGCGACAGATAC – 3’ 
Toll-2 Reverse 5’ – TAATACGACTCACTATAGGTGTACTCCGACTCGATGCTG – 3’ 
Toll-7 Forward 5’ – TGCACTGGAAGATAGCAGCTCGAA – 3’ 
Toll-7 Reverse 5’ – AGCAGCCAGCAAGGGAATATACGA – 3’ 
Toll-9 Forward 5’ – TTGCAAAGTCTTGGGTCGCTTTCG – 3’ 
Toll-9 Reverse 5’ – TCTTTGAGGTCAGCAAGGAGCACT – 3’ 
cnk Forward 5’ – ATCGCCGCTAGACTTTCCTTTGGA – 3’ 
cnk Reverse 5’ – CAACAGCAGCAGCAGCTACAACAT – 3’ 
Dcr-2 Forward 5’ – AGCTCCGGCTCGAAGAGATTGAAA – 3’ 
Dcr-2 Reverse 5’ – TCCACAAACGTGGATGTGCCAAAG – 3’ 
Ars2 Forward 5’ – GCTTGTTGAAGATGTGCTTGCGGA – 3’ 
Ars2 Reverse 5’ – AAGCGAACACTCAGGAGTTAGCCA – 3’ 
Chc Forward 5’ – TAATACGACTCACTATAGGTATAACTTTCA – 3’ 
Chc Reverse 5’ – TCGGTTTCTGGTTTAAGATTCGGT – 3’ 
CycT Forward 5’ – AATGTCTGGCCACTCTGGACTGAA – 3’ 
CycT Reverse 5’ – AATTGCCCTATTCCCAGAGCCAGA – 3’ 
Tep II (ProProx) Forward 5’ – CGAGTTACTGGAAGACAGGCAAAC – 3’ 
Tep II (ProProx) Reverse 5’ – AGCCGGCATCAAATCAAGACTGAC – 3’ 
Tep II (Downstream) Forward 5’ – TGGATTCACCCGCAGATGAGAACT – 3’ 
Tep II (Downstream) Reverse 5’ – TACTGTGATTGGTCTTCAGGCGCT – 3’ 
Toll-8 (ProProx) Forward 5’ – ATGCTAATTCTACCTGCCCACCGA – 3’ 
Toll-8 (ProProx) Reverse 5’ – CTATGCAATCCGAACGCAAACGCA – 3’ 
Toll-8 (Downstream) Forward 5’ – TCTTCTTTCGCTGAGGGTTGTGGA – 3’ 
Toll-8 (Downstream) Reverse 5’ – TGGGAATTCAGTTCGTTGCTTGCC – 3’ 
CG13325 (ProProx) Forward 5’ – AAGCTGATTTCGCTTCCCTGTTGC – 3’ 
CG13325 (ProProx) Reverse 5’ – GGTTTGTGTGTCGCCTTCACCTTT – 3’ 
CG13325 (Downstream) Forward 5’ – GAATGTGTCGCGGTTTGTCAGCTT – 3’ 
CG13325 (Downstream) Reverse 5’ – GCGGTTGTTGTTGTTGCTGCTTTG – 3’ 
Tep II (short reads) Forward 5’ – CAGTGTGAATCGTCGCTAGC – 3’ 
Tep II (short reads) Reverse 5’ – GAAAACCGACCGATCGCC – 3’ 
Toll-8 (short reads) Forward 5’ – CAGTTTTTGAGTTGACTTCG – 3’ 
Toll-8 (short reads) Reverse 5’ – AACGCGCGTCCGCTCGGC – 3’ 
CG13325 (short reads) Forward 5’ – ATGAAAGCATTGCGGTTCA – 3’ 
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CG13325 (short reads) Reverse 5’ – GTTCCCGCAAGTATTTGTT – 3’ 
 
 
 
 
 
  
	  36	  
CHAPTER 3. Transcriptional Pausing Orchestrates a Rapid Antiviral Response in 
Drosophila melanogaster3 
 
1. Abstract 
 
Innate immune responses are characterized by precise gene expression 
whereby gene subsets are temporally induced to limit infection, although the 
mechanisms involved are incompletely understood. We show that antiviral immunity in 
Drosophila requires the transcriptional pausing pathway, including negative elongation 
factor (NELF) that pauses RNA polymerase II (Pol II) and positive elongation factor b (P-
TEFb), which releases paused Pol II to produce full-length transcripts. We identify a set 
of genes that is rapidly transcribed upon arbovirus infection, including components of 
antiviral pathways (RNA silencing, autophagy, JAK/STAT, Toll, and IMD) and various 
Toll receptors. Many of these genes require P-TEFb for expression and exhibit pausing-
associated chromatin features. Furthermore, transcriptional pausing is critical for antiviral 
immunity in insects because NELF and P-TEFb are required to restrict viral replication in 
adult flies and vector mosquito cells. Thus, transcriptional pausing primes virally induced 
genes to facilitate rapid gene induction and robust antiviral responses. 
 
2. Background 
 
The innate immune system is an ancient, highly conserved mode of defense 
against pathogens and the sole method of protection for invertebrates and plants. A 
critical aspect of innate immunity is the rapid activation of gene expression programs to 
generate effectors that restrict pathogens [58,59]. The best-characterized example is the 
lipopolysaccharide (LPS)-induced macrophage response, which is classically described 
in two stages: the rapid protein synthesis-independent induction of immediate-early 
genes (termed the primary response), followed by the subsequent protein-synthesis-
dependent induction of secondary response genes [58,59]. Studies have implicated the 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3 Portions of this chapter is reprinted from Xu J, Grant G, Sabin LR, Gordesky-Gold B, Yasunaga 
A, Tudor M, Cherry S. (2012). Transcriptional pausing controls a rapid antiviral innate immune 
response in Drosophila. Cell Host & Microbe. 2012 Oct 18;12(4):531-43, with permission from 
Elsevier. 
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step of transcription initiation in regulating these waves of gene expression, in both 
mammals [58] and insects [41,109]. In this mode of regulation, pathogen recognition 
leads to activation of specific transcription factors that recruit RNA Polymerase II (Pol II) 
and general transcription factors to promoters, thereby inducing gene expression 
[58,166]. While this is often considered canonical, how other transcriptional regulatory 
mechanisms play a role in orchestrating immune responses are less clear, particularly 
across a diverse range of pathogens and hosts. Furthermore, inducible host programs 
that control pathogens in disease-transmitting insect vectors, particularly viruses, are not 
well defined. 
Transcriptional pausing is a mode of gene regulation that occurs as a step in the 
transcription cycle downstream of initiation [167]. Recent studies suggest that a subset 
of inducible genes can also be tightly regulated at this step [168,169]. Initially described 
to negatively regulate a handful of genes, including Drosophila heat shock loci, recent 
studies reveal that a larger set of genes is positively regulated by this step of the 
transcription cycle [157,162,168,170-175]. At these loci, Pol II is recruited and engaged 
in transcription, but only synthesizes short, abortive precursor transcripts [169]. Pol II is 
paused and unable to transition into productive elongation by associating with Negative 
Elongation Factor (NELF) and DRB-sensitivity Factor (DSIF). This process competes 
with nucleosomes for occupancy in the promoter-proximal region, thereby keeping these 
loci more accessible for future activation [162]. Upon stimulation, Pol II is released from 
pausing by recruitment of Positive Elongation Factor (P-TEFb), leading to the 
phosphorylation of NELF, DSIF and Serine-2 of the Pol II CTD (Pol II Ser-2-P). This 
causes the rapid transition to the elongating form of Pol II (Pol II Ser-2-P/Ser-5-P) and 
functional mRNA production [169]. In some systems, open histone marks near the 
promoter region, including Histone 3 Lysine 4 trimethylation (H3K4me3), are associated 
with transcriptionally paused loci [176,177]. Collectively, these studies indicate that 
transcriptional pausing promotes an open chromatin state near the transcription start site 
for some inducible genes, thereby potentiating their future activation. A subset of 
mammalian LPS-dependent primary response genes is regulated by pausing [176,178]. 
Whether this is evolutionarily conserved or required for antiviral defense is unknown. 
Drosophila melanogaster is a powerful genetic organism to study how 
transcriptional mechanisms govern innate responses [29,30,83,179,180]. Not only was 
transcriptional pausing initially discovered and extensively characterized in Drosophila 
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[169,181], its sole reliance on innate defenses provides a robust model system for study 
[29,56,128,179]. Indeed, Toll was discovered using Drosophila, leading to subsequent 
discovery of the mammalian Toll-Like Receptors (TLRs) [29,60,61]. This system has 
also been used to study antiviral immunity of insect vectors, as many human arthropod-
borne viruses (arboviruses) can infect and replicate in flies, including the Alphavirus 
Sindbis virus (SINV), Rhabdovirus Vesicular Stomatitis virus (VSV), Bunyavirus Rift 
Valley Fever Virus (RFV), and Flavivirus Kunjin (KUN) [117,122,144,153,182]. While 
transcriptional programs against bacteria and fungi are well-established in insect models 
[31], much less is known about the host programs that restrict viruses [56]. Some 
antiviral transcriptional pathways, including the classic JAK/STAT pathway, have found 
to be conserved in Drosophila [71,72,88,183], but are insufficient to account for all 
antiviral defenses.  
To discover additional antiviral transcriptional mechanisms, we used RNAi 
screening against disparate arboviruses in Drosophila and identified multiple 
components of the transcriptional pausing pathway (including NELF, DSIF, and P-TEFb) 
as essential mediators of insect antiviral defense. Genome-wide transcriptional profiling 
led us to characterize a complex virally-induced genetic program, including components 
of known antiviral pathways (Toll, IMD, JAK/STAT, autophagy, and RNA silencing) and a 
number of Toll receptors, including one recently found to play a role in antiviral defense 
[29,56,64]. This transcriptional response is rapid and consists of two classes: translation-
independent and dependent genes. Furthermore, we find that over half of this response 
relies on the pausing-release factor P-TEFb and has biochemical features of inducible 
paused loci, including the promoter-proximal enrichment of pausing machinery (Pol II, 
NELF, and DSIF) and NELF-dependent basal synthesis of short, abortive transcripts. 
We also demonstrate that transcriptional pausing controls infection at the organismal 
level, as NELF and P-TEFb restrict viral replication in flies. We extend our findings to 
mosquitoes, the natural hosts of some arboviruses, and find that NELF and P-TEFb 
restrict infection in Aedes aegypti cells. Our data collectively suggest that transcriptional 
pausing enhances promoter accessibility of virally responsive loci to allow for rapid 
activation upon infection. Once induced, this program produces a robust and 
multifaceted response to restrict viral infection. 
 
3. Results 
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NELF Restricts Viral Infection In Drosophila Cells.  
To identify host factors that broadly restrict viral infection, we performed a small-
scale RNAi screen in Drosophila cells using disparate arthropod-borne RNA viruses 
(VSV and SINV) whose natural cycle involves transmission between insects and 
vertebrates [4,122,144]. Depletion of two components of the four subunit NELF complex, 
which is involved in transcriptional pausing [167], increased infection by these viruses 
(S.C., unpublished data). To further investigate NELF’s role in antiviral defense, we 
generated independent dsRNAs targeting alternative regions of the identified subunits, 
NELF-B and NELF-D (TH1). We found that depletion of NELF-B or NELF-D with an 
independent dsRNA similarly increases susceptibility of cells to SINV and VSV infection 
compared to non-targeting controls, as measured by percent infection (Figure 1A). The 
infection percentage is determined by fluorescence microscopy of GFP, a reporter 
expressed from the genome of both viruses [184,185]. Quantification reveals >2-fold 
increase in VSV and SINV infection (Figure 1B). Northern blot analysis shows efficient 
knockdown (Figures S1A and S1B). We also measured viral replication by Northern blot 
and found increased VSV mRNA levels in NELF-B or NELF-D-depleted cells (Figure 
1C). Similarly, we found that SINV RNA levels are increased in NELF-deficient cells 
(Figure 1D). Furthermore, we found that NELF-B can also restrict VSV and SINV 
infection in Drosophila S2 and Kc167 cells (Figures 1E, 1F, S1C, and S1D). From these 
findings, we conclude that NELF restricts viral pathogens from disparate families in a 
variety of Drosophila cell lines. 
 
Transcriptional Pausing Is Required For Defense Against Disparate Arboviral 
Pathogens. 
To determine whether NELF’s antiviral activity is mediated through involvement 
in the transcriptional pausing pathway, we tested whether DSIF or P-TEFb, two 
complexes required for pausing and release, are antiviral against VSV and SINV (Figure 
2A). DSIF, comprised of Spt4 and Spt5, binds NELF and helps facilitate polymerase 
pausing about 50 base pairs downstream of the transcription start site [168]. P-TEFb, 
comprised of Cdk9 and CyclinT (CycT), releases this pause to promote transcriptional 
elongation and functional mRNA production [168,169]. We find that both of these 
complexes restrict VSV and SINV infection, as their depletion causes a significant 
increase in infection (Figures 2B and 2C). In addition, Northern blotting indicates that 
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both VSV and SINV mRNA levels are increased in cells depleted of DSIF or P-TEFb 
subunits (Figures 2D and 2E). We also found that P-TEFb is antiviral in S2 and Kc167 
cells (Figures S2A and S2B). Lastly, we determined whether this pathway is antiviral 
against other medically relevant arboviruses and found that P-TEFb restricts KUN and 
RFV infection in Drosophila cells, along with the natural Drosophila pathogen Drosophila 
C virus (DCV) (Figures S2C and S2D). 
We found that machinery that helps to pause Pol II (NELF, DSIF) and P-TEFb 
that alleviates this pause both have antiviral phenotypes (Figures 1 and 2), suggesting 
that these complexes act concertedly to promote antiviral defense. This is consistent 
with recent studies reporting that NELF-mediated pausing positively regulates gene 
expression by promoting open chromatin structure in the promoter-proximal region of 
genes, facilitating their future activation by P-TEFb [176,178]. This is in contrast to other 
genes, most classically the heat shock loci, where NELF and DSIF negatively regulate 
gene expression [186]. Altogether, these data suggest that NELF’s antiviral activity is 
mediated through the transcriptional pausing pathway to positively control gene 
expression, through regulation of antiviral gene induction. 
 
Viral Infection Induces A Rapid Antiviral Host Response 
To identify virally-induced genes that are regulated by transcriptional pausing, we 
first analyzed a published Drosophila microarray study that found two-thirds of 
approximately 250 NELF-dependent genes are positively controlled by NELF [157]. One 
immune-associated gene called Tep II was genetically dependent on NELF for its basal 
expression and had enrichment of pausing machinery near its promoter [157]. There 
was increased nucleosome occupancy in the promoter region of Tep II upon NELF 
depletion, explaining how the loss of NELF could lead to reduced expression [157]. This 
is provocative, because Tep II is a complement-related gene that is induced by SINV 
infection in Drosophila and mosquito cells [187]. 
Based on these findings, we first tested whether virus infection leads to Tep II 
induction [157]. We also tested Peptidoglycan recognition protein SA (PGRP-SA), a 
bacterial-recognition protein of the Toll pathway, that was shown to be genetically 
dependent on NELF, but its biochemical status had been unexplored [65,157]. Given 
that pausing-regulated genes are often rapidly induced [170,188], we challenged 
Drosophila cells with virus and monitored gene induction at 4 hours post-infection. We 
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found that both VSV and SINV can induce Tep II expression at this early time-point post-
infection, as measured by RT-qPCR (Figure 3A). This is prior to the initiation of viral 
replication at approximately 6 hours post-infection (Figure 3A, not shown) [189,190]. In 
contrast, we found that PGRP-SA is not induced (Figure 3A), suggesting that only a 
subset of NELF-regulated genes is responsive to viral infection. 
Next, we set out to identify the full spectrum of virally induced genes that may be 
pausing-regulated. To this end, we performed global gene expression profiling of 
Drosophila cells that were either uninfected or infected with VSV for 4 hours. We profiled 
two independent experiments, identifying 540 upregulated and 96 downregulated genes 
with at least a 2.8-fold change in mRNA levels (q<0.005; Figure 3B, Tables S1A and 
S1B). Gene Ontology (GO) enrichment analysis revealed that several known immune 
and antiviral pathways are over-represented within this dataset (p<0.05, Figure 3C, 
Tables S1C and D), including humoral immune response and immune system 
development (Figure 3C and Table S1C). We also identified components of major 
antiviral pathways known to restrict viruses in Drosophila including RNA interference, 
JAK/STAT, IMD, and autophagy pathways (Figure 3C and Table S1D) 
[56,71,72,88,117,183]. Interestingly, we also found that transcriptional pausing pathway 
components NELF-A and CycT are induced (Figure 3B and Table S1D). Altogether, our 
findings suggest that this rapidly induced early transcriptional program has antiviral 
effector function. 
 
Viral Infection Induces A Transcriptionally Complex Antiviral Host Response 
Next, we tested whether these virally responsive genes are inducible by both 
VSV and SINV. We selected candidates from our dataset with known antiviral function 
(Ars2, Dcr-2), genes not previously implicated in Drosophila antiviral immunity (Ago1, 
cnk, Nos), and the CycT subunit of the P-TEFb complex (Figure 2). We found that both 
viruses induce these genes at 4 hours post-infection (Figures 4A and 4B). Since two Toll 
receptors (Toll-2 and Toll-8) were VSV-induced in our profiling data, we also tested the 
panel of nine Drosophila Toll receptors. We found that Toll, Toll-2, Toll-7, and Toll-8 are 
inducible by both VSV and SINV, while the remaining Tolls are not inducible by both 
viruses (Figures 4A and 4B, not shown). 
Many rapidly inducible, pausing-regulated genes are activated in the absence of 
protein synthesis and are a subset of primary response genes [191-193]. To determine 
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whether the induction of our candidate genes requires new protein synthesis, we 
compared their transcript levels upon viral infection in the presence and absence of 
Cycloheximide (CHX), a translation inhibitor. We found that Tep II, Toll, and Toll-7 are 
inducible by VSV and SINV in a translation-independent manner (Figure 4C and 4D). In 
contrast, Nos was virally induced in a Cycloheximide-dependent manner (Figure 4C and 
4D). Hence, our findings suggest this early virally induced gene expression program is 
multifaceted, involving both primary responses and secondary responses. 
 
Some Virally Induced Genes Are NELF And P-TEFb-dependent.  
To determine whether the induction of these translation-independent genes 
requires the transcriptional pausing machinery, we first depleted NELF (NELF-B, D) or 
P-TEFb (Cdk9) by RNAi, challenged Drosophila cells with VSV or SINV, and monitored 
their induction by RT-qPCR. We found that VSV- and SINV-induced expression of Tep 
II, Toll, Toll-2, Toll-7 and Toll-8 are attenuated upon NELF or P-TEFb knockdown 
(Figures 5A and 5B). In addition, we found that the basal levels of Tep II and Toll, but not 
Toll-7 or Toll-8, are reduced upon NELF and P-TEFb-depletion (Figure S3A). Expression 
levels of housekeeping genes Clathrin Heavy Chain (Chc) and Rp49 are unaffected by 
the loss of pausing factors, with or without viral infection (Figures 5D and S3B). This is 
consistent with reports suggesting that transcriptional pausing is a step in the 
transcription cycle of many constitutively active housekeeping genes, but not necessarily 
rate-limiting for their expression [157]. Hence, the requirement for NELF and P-TEFb are 
not necessarily to maintain basal levels per se. 
We also found that pausing regulates only a subset of the response since not all 
virus-induced genes are NELF- and P-TEFb-dependent. One example is CG13325 
(Figure 5C), a VSV-induced gene from our profiling dataset that is also found to be 
induced by DCV in flies [88]. In addition, we tested whether NELF or P-TEFb is required 
for induction of antimicrobial peptides (AMPs) Diptericin B (DptB) and Attacin B (AttB), 
which are classic peptidoglycan (PGN)-inducible genes that require NFkappaB [83,109]. 
We found their induction to be independent of NELF and P-TEFb (Figures 5E and S3C). 
These findings demonstrate that transcriptional pausing controls specific subsets of 
pathogen-induced genes. 
To characterize the spectrum of virally induced genes that require pausing 
factors, we performed genome-wide profiling and found that P-TEFb regulates about 
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52% of the 540 virally induced genes (≥ 1.5 fold down-regulation, 279 genes, Figure 5F, 
and Table S1A). This is a highly significant enrichment compared to published studies 
showing that only 1-5% of the transcriptome is affected by the loss of NELF or P-TEFb in 
Drosophila and mammalian systems using similar approaches [157,194-196]. 
Altogether, our findings suggest that transcriptional pausing plays a major role in 
regulating the virally induced gene expression program. 
 
Virally Induced, P-TEFb-Dependent Genes Have Chromatin Features of Paused 
Loci.  
Several biochemical traits have been described for pausing-regulated inducible 
genes in the literature, including (1) promoter-proximal enrichment of NELF and DSIF, 
(2) production of short, abortive transcripts from the 5’ transcriptional start site, (3) 
promoter-proximal enrichment of the open chromatin mark H3K4me3, and (4) a peak of 
Pol II localization at the promoter, but largely absent from the body of the gene [162-
164]. Genome-wide studies have characterized these cellular features [162,163,178] 
and we analyzed this data to determine whether virally responsive genes have these 
traits. Since Tep II has been shown to be regulated by transcriptional pausing both 
genetically and biochemically [157], it serves as a proof-of-principle for our analysis 
(Figure 6A). We found that the Tep II promoter-proximal region is (1) enriched for the 
paused machinery (NELF, DSIF), (2) produces abundant short, abortive transcripts from 
the 5’ transcriptional start site, (3) exhibits promoter-proximal enrichment of H3K4me3, 
and (4) has a peak of Pol II restricted to the promoter-proximal region (Figure 6A). Next, 
we analyzed the Toll receptors and found that only the four pan-virally-inducible Toll 
receptors (Toll, Toll-7, Toll-2 and Toll-8) also have these features (Figures 6B, S4A, 
S4B, and S4C), while the remaining five Toll receptors do not (Figures 6D and S4D, data 
not shown). Furthermore, CG13325 also lacks the pausing-associated chromatin traits 
(Figure 6C), which is virally induced independent of NELF and P-TEFb (Figure 5C). 
PGN-inducible and NFkappaB-dependent AMP genes, DptB and AttA, also lacked these 
features (Figures S4E and S4F). As expected, housekeeping genes differ from the virally 
inducible pausing-regulated loci. Rp49 and Chc have Pol II occupancy spanning the 
body of the gene, indicative of robust functional mRNA production (Figures S4G and 
S4H). The virally induced genes that are NELF and P-TEFb-dependent lack this 
downstream occupancy, consistent with their low basal expression and dependence on 
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transcriptional pausing for induction (Figures 4, 5, 6, and S4). Lastly, we analyzed 
available Pol II occupancy from Mod Encode for some of our pausing-regulated virally 
induced genes in other cell types [165,197]. Tep II and Toll have the same basal 
promoter-proximal enrichment of Pol II in Kc167 and CME W1 cl.8+ cells (Figures S4I 
and S4J), suggesting that this pausing signature may be conserved. 
Next, we performed chromatin immunoprecipitation (ChIP) of RNA Pol II using an 
antibody that recognizes both initiating and elongating forms of Pol II (Ser-2-P/Ser-5-P) 
at virally induced loci in Drosophila cells. We found significant Pol II occupancy in the 
promoter-proximal regions of Tep II and Toll-8 in the absence of infection (Figures 6E 
and 6F), but little signal near the promoter of the NELF-independent gene CG13325 
(Figure 6G). As expected, there is also little Pol II signal in the body of Tep II, Toll-8, and 
CG13325 prior to infection (Figures 6E, 6F, and 6G), consistent with our mRNA and 
ChIP analyses (Figures 5, 6A, 6B, and 6C). NELF-depletion leads to a reduction in Pol II 
occupancy near the Tep II promoter region (Figure 6E), consistent with our mRNA 
analysis and published findings [157]. We found that 5’ short reads are also detectable in 
uninfected Drosophila cells for Tep II and Toll-8, but not CG13325 (Figure 6H), as 
measured by RT-qPCR. Importantly, the synthesis of these short transcripts is NELF-
dependent (Figure 6H). These findings, in addition to our genetic studies, suggest that 
NELF-dependent abortive transcription promotes Pol II occupancy at a basal state. 
Moreover, we found that VSV infection triggers a significant increase in Pol II 
occupancy in both promoter-proximal and distal regions of Tep II, Toll-8, and CG13325 
(Figures 6E, 6F, and 6G). This occupancy was NELF-dependent for Tep II and Toll-8, 
but not CG13325 (Figures 6E, 6F, and 6G). For Tep II and Toll-8, pausing helps facilitate 
Pol II release into the body of the genes upon viral infection and supports our finding of a 
genetic dependence on NELF for functional mRNA production upon viral infection 
(Figure 5). As a control, we tested the housekeeping gene RpL3 and found no significant 
difference in Pol II occupancy upon viral infection in the promoter-proximal or distal 
regions (not shown). Thus, we have biochemically and genetically identified a pausing-
dependent, virally responsive gene expression program. 
Lastly, we examined the pausing hallmarks at the chromatin level for the virally 
induced genes as a whole. Published genome-wide characterization of these features 
suggests that approximately 50% of the genome, including constitutively active 
housekeeping genes, have pausing traits to varying degrees (7466 genes). However, 
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only 13% (1866 genes) are defined as strongly paused [162]. We similarly defined 
candidates as strongly paused if they had a statistically significant enrichment within +/- 
500 kb of the transcription start site for at least three of these four traits: (1) NELF, (2) 
DSIF, (3) Pol II and (4) basal short transcript production. Our analysis reveals that 14% 
of the genome has these features (2225 genes, Figure 6I), consistent with published 
findings. Strikingly, we found that 47% of the P-TEFb-dependent genes are strongly 
paused at the chromatin level (130 genes, Figure 6I, Table S1A), a significant 
enrichment compared to the genome as a whole (p<0.0001, Figure 6I). GO enrichment 
analysis identified 16 categories within this set of genes (p<0.05, Figure S4K and Table 
S2). In addition to the immune response category that was also enriched within the 
dataset as a whole (Figure 3C and Table S2), other categories include MAPK signaling 
and genes involved in cytoskeleton organization (Table S2). 
 
Transcriptional Pausing Restricts Viral Replication In Adult Flies And Mosquito 
Cells.  
To determine whether transcriptional pausing plays an essential antiviral role at 
the organismal level, we depleted two major pathway components, NELF-B and Cdk9, in 
adult flies using inducible RNAi, as null mutants are lethal [198]. We used the Gal4/UAS 
system to drive expression of UAS-inverted repeat transgenes (UAS-NELF-B IR or UAS-
Cdk9 IR), which bear long hairpin dsRNA constructs to target the endogenous 
transcripts in vivo. To bypass developmental requirements, we drove the expression of 
hairpins using a heat shock (hs) promoter and found that we can deplete NELF-B or 
Cdk9 mRNAs (Figure S5). We challenged NELF-B-depleted, Cdk9-depleted, or control 
flies with carrier (PBS), VSV, or SINV, and monitored for viral replication using plaque 
assays. We found that NELF-B-deficient flies and Cdk9-deficient flies have significantly 
higher VSV and SINV titers compared to wildtype flies at two time points post-infection 
(Figures 7A, 7B, 7C, and 7D). To determine whether transcriptional pausing regulates a 
similar gene expression program in vivo, we challenged files with VSV and found that 
Tep II was induced 24 hours post-infection in a NELF-B-dependent manner (Figure 7E). 
These findings suggest that transcriptional pausing plays a critical role in Drosophila 
antiviral immunity at the organismal level.  
Lastly, to determine whether this antiviral mechanism is conserved in other 
insects, including mosquito vectors, we examined whether NELF and P-TEFb can 
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restrict viral replication in mosquito cells. We used RNAi to deplete Aedes aegypti Aag2 
cells of NELF-B (AAEL014752) or Cdk9 (AAEL013002) and compared the percentage of 
infected cells to non-targeting controls using microscopy. We found that NELF-B and 
Cdk9 restricted these two viruses in mosquito cells (Figures 7F and 7G). In addition, we 
used Northern blotting to measure viral RNA levels. We found VSV and SINV mRNA 
levels are increased in NELF-B or Cdk9-depleted cells as compared to control cells 
(Figure 7H). Our findings using both Drosophila and Aedes systems suggest that 
transcriptional pausing plays an important and conserved role in insect antiviral defense. 
 
4. Discussion 
 
Through RNAi screening against disparate arboviral pathogens in Drosophila, we 
discovered that the transcriptional pausing pathway is broadly antiviral in insects 
(Figures 1, 2, and 7). This led us to characterize a rapidly-inducible host response that 
has components from all major known antiviral pathways, including RNA silencing genes 
Ars2, Cbp80, and Dcr-2 that control a range of RNA viruses in insects (Figure 3 and 
Table S1D) [119,122-124,126,182,199,200]. 52% of this virus-induced response 
requires P-TEFb for activation (Figure 5F), which is highly overrepresented compared to 
the genome as a whole [157,162,194-196]. We find that 47% of the P-TEFb-dependent 
response has multiple chromatin features of transcriptional pausing, which is also 
enriched compared to 14% of the genome as a whole (p<0.0001, Figure 6I). These strict 
biochemical criteria include the presence of the pausing machinery (Pol II, NELF, and 
DSIF) and the basal synthesis of 5’ short transcripts. Mechanistically, we find that RNA 
Pol II is enriched in the promoter-proximal region for the virally induced pausing-
regulated genes and this occupancy is NELF-dependent (Figures 6E and 6F). At these 
loci, short abortive transcripts are synthesized in a NELF-dependent manner (Figure 
6H). Upon viral infection, RNA Pol II is rapidly recruited downstream, leading to the 
production of full-length mRNAs (Figures 5 and 6). Moreover, we find that pausing is 
antiviral in various Drosophila cell lines, mosquito cells, and adult flies (Figures 1 and 7), 
suggesting that a transcriptional pausing-regulated gene expression program plays a 
broad and conserved role in insect antiviral defense.  
Compared to bacterial infections, less is known about the transcriptional 
programs that restrict viral pathogens in insects and no rapid host responses have been 
characterized [29,31,87,88,187,201-203]. We discovered an early transcriptional 
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response to viral infection that includes components of major antiviral pathways (Figures 
3, 4, and Table S1) [29,56]. The highly conserved JAK/STAT signaling pathway is the 
best-studied antiviral transcriptional response. It is activated by and restricts DCV in 
adult flies and Dengue virus in adult mosquitoes, but has not shown to be active in cell 
culture [87,88,204]. We found that the Drosophila homolog of JAK (hop) is 
transcriptionally induced by viral infection along with 8 pathway-associated genes (Table 
S1D) [88]. However, induction of JAK/STAT-dependent target genes was not observed 
and STAT binding sites were not enriched within our dataset (data not shown) [88]. 
There are two NFkappaB-dependent signaling pathways in Drosophila, the Toll and IMD 
pathway, which are implicated in antiviral defense [63,71,72,183]. We found that Toll 
itself and the IMD pathway component Relish were are induced by infection, but not 
other pathway components nor their canonical downstream AMP targets (Figures 3, 4, 
Table S1D) [41,68,109,205-207]. Moreover, our dataset lacks enrichment for NFkappaB 
binding sites (data not shown) [83]. These findings suggest that our rapidly induced 
antiviral program is not likely dependent on JAK/STAT, Toll, or IMD pathways. Future 
work characterizing the upstream signals leading to P-TEFb recruitment may further 
shed light into this response. 
Interestingly, we found that three other Toll receptors (Toll-2, Toll-7, and Toll-8) 
are transcriptionally induced by VSV and SINV infection (Figure 4). We recently found 
that Toll-7 is antiviral against VSV via the autophagy pathway and 9 other autophagy-
associated genes are also rapidly induced by viral infection (Table S1D) [64,117]. Toll-2 
may play a minor role in antibacterial immunity [208,209]. Toll-8 negatively regulates 
local immune responses to bacterial challenge [210,211]. Whether Toll-2, Toll-8, or 
additional Drosophila Toll receptors play roles in antiviral defense remains an open 
question. Furthermore, whether pausing regulates mammalian TLR expression or other 
pattern recognition receptors downstream of viral infection is unknown. Since our 
genome-wide profiling experiments reveal that known antiviral pathways are virally 
induced (Figures 3, 4, and Table S1D), additional genes within our gene-set may also 
play direct roles in antiviral immunity. Further exploration of these rapidly induced genes, 
both paused and non-paused, may reveal additional aspects of the innate immune 
arsenal. 
One of the best-characterized innate immune transcriptional response is the 
LPS-induced primary and secondary response program in macrophages [58,59]. The 
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primary response is independent of de novo protein synthesis and has differences in 
chromatin structure and CpG content compared to the secondary response [176,212]. 
Recent studies reveal that a subset of these LPS-induced primary response genes, 
including TNF-alpha, is controlled by transcriptional pausing in vitro [176]. This rapid 
antiviral transcriptional program parallels many aspects of the LPS-induced macrophage 
response, as both translation-independent and translation-dependent targets were 
identified (Figure 4). Interestingly, some LPS-induced primary response genes, like the 
transcription factor IkappaBzeta, control downstream secondary responses [213]. 
Whether any of our virally induced primary response genes drive subsequent gene 
expression is an open question. We find that 32 genes are both pausing-regulated and 
involved in transcription as defined by annotated GO terms, including transcription 
factors and chromatin modifiers. Characterization of their potential roles in driving 
secondary responses may reveal insights into the sequential nature of these early 
immunologic events. 
Transcriptional pausing restricts disparate arboviruses in cell culture and at the 
organismal level. Whether other insect immune responses are controlled by similar 
mechanisms is largely unknown [214]. Furthermore, whether pausing similarly controls 
antiviral defense in mammals is also unknown. Nevertheless, our findings in conjunction 
with published literature suggest that transcriptional pausing is associated with rapid 
gene induction and may serve as a robust mechanism for immediate defense against a 
variety of pathogens across diverse hosts [170,176,215]. Future work examining the role 
of transcriptional pausing in these various immunologic contexts may help define how 
paused genes are differentially activated and also lead to the development of therapeutic 
strategies for infectious diseases. 
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Figure 1. NELF Restricts Viral Infection in Drosophila Cells. (A) Drosophila cells 
were treated with dsRNA against a control (Bgal), NELF-B, or NELF-D. Infected cells 
expressing a VSV-encoded GFP (moi = 0.2) or SINV-encoded GFP (moi = 5) are shown 
in green, nuclei in blue.(B) Quantification of images in (A) as normalized (norm.) to 
controls is illustrated. Mean ± SD of three independent experiments is shown; ∗p < 
0.05.(C and D) Northern blot analysis of cells pretreated with the indicated dsRNAs and 
infected with (C) VSV or (D) SINV is demonstrated.(E and F) S2 (E) and Kc167 (F) cells 
were treated as in (A). Quantification of images as percentage of infection, normalized to 
controls, is illustrated. Mean ± SD of three independent experiments is shown; ∗p < 
0.05.See also Figure S1.  
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Figure 2. Transcriptional Pausing and Release Restrict Viral Infections in 
Drosophila Cells. (A) Schematic of transcriptional pausing and release is illustrated. (B) 
Drosophila cells treated with the indicated dsRNAs were challenged with VSV (moi = 
0.2) or SINV (moi = 5) and monitored by fluorescence microscopy.(C) Quantification of 
images in (A) is demonstrated. Mean ± SD of three independent experiments is shown; 
∗p < 0.05.(D and E) Northern blot analysis of cells pretreated with the indicated dsRNAs 
and infected with (D) VSV or (E) SINV is presented. See also Figure S2. 
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Figure 3. An Antiviral Transcriptional Program Is Rapidly Induced by Viral 
Infection. (A) Drosophila cells were infected with VSV (moi = 10) or SINV (moi = 25) for 
4 hr. RT-qPCR was performed for Tep II and PGRP-SA, normalized to Rp49, and shown 
compared to uninfected (Uninf) controls. Mean ± SD of three independent experiments is 
shown; ∗p < 0.005.(B) Heatmap of raw signal levels for genes differentially expressed at 
4 hr post VSV-infection (moi = 10), performed in biological duplicates (q < 0.005), is 
illustrated. Shown are 636 transcripts (540 upregulated, 96 downregulated) with at least 
2.8-fold change in VSV-infected cells. Genes of interest are shown on the right.(C) 
Enriched GO terms for the 540 virally induced genes (p < 0.05).See also Tables S1A–
S1D. (Microarray performed by M. Tudor).  
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Figure 4. Viral Infection Triggers a Rapid and Transcriptionally Complex Antiviral 
Expression Program. (A and B) Drosophila cells were infected with (A) VSV (moi = 10) 
or (B) SINV (moi = 25). RT-qPCR was performed for the indicated genes at 4 hr post 
infection, normalized to Rp49, and shown relative to uninfected controls. Mean ± SD of 
three independent experiments is shown; ∗∗p < 0.005, ∗p < 0.05.(C and D) Drosophila 
cells were untreated or pretreated with 10 µg/ml CHX and infected as in (A) and (B). RT-
qPCR was performed for the indicated genes. Mean ± SD of three independent 
experiments is shown; ∗p < 0.005. n.s, not significant.   
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Figure 5. A Subset of Virally Induced Genes Is NELF and P-TEFb Dependent. (A–D) 
Drosophila cells were treated with the indicated dsRNAs and infected with VSV (moi = 
10) or SINV (moi = 25). RT-qPCR of the indicated genes at 4 hr post infection, 
normalized to Rp49, is shown as relative to uninfected controls. Mean ± SD of three 
independent experiments is shown; ∗∗p < 0.005, ∗p < 0.05.(E) Cells were treated with 
PGN for 6 hr. AttB expression was measured and normalized as stated above. Mean ± 
SD of three independent experiments is shown; ∗p < 0.005.(F) Analysis of Cdk9 
dependency of the 540 VSV-induced genes (279 genes, ≥1.5-fold down regulation) is 
presented. Black and gray indicate the percentage of Cdk9-dependent and independent 
genes, respectively. See also Figure S3. (Microarray analysis performed by M. Tudor) 
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Figure 6. Virally Induced, P-TEFb-Dependent Genes Have Chromatin Features of 
Transcriptionally Paused Loci. (A–D) Mapping of Pol II (Rbp3), NELF (NELF-B), DSIF 
(Spt5), H3K4me3, and short RNA reads for (A) Tep II, (B) Toll-8, (C) CG13325, and (D) 
Toll-5 is illustrated.(E–G) ChIP of RNA Pol II (CTD4H8) at (E) Tep II, (F) Toll-8, (G) 
CG13325 in cells treated with the indicated dsRNAs and either uninfected or infected 
with VSV (moi = 10) using primers span the promoter-proximal or downstream regions. 
The data are represented as a percentage of input. Mean ± SD for three independent 
experiments is shown; ∗p < 0.05.(H) RT-qPCR of 5′ short reads for Tep II, Toll-8, and 
CG13325 with the indicated dsRNA treatment in Drosophila cells is presented. 
Transcripts were normalized to Rp49 and shown as relative to controls. Mean ± SD of 
three independent experiments is shown; ∗p < 0.05. n.d., not detectable.(I) Comparison 
of VSV-induced, Cdk9-dependent genes (Cdk9-Dep) with pausing-associated chromatin 
features to the genome-wide distribution (∗p < 0.0001) is illustrated. See also Figure S4 
and Table S2. (Reanalysis of genome-wide data was performed by Gregory Grant).  
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Figure 7. NELF and P-TEFb Restrict Viral Infection in Flies and Mosquito Cells. (A–
D) Adult flies of the indicated genotypes were challenged with (A and B) VSV or (C and 
D) SINV. Viral titers were measured with mean ± SD of three independent experiments; 
∗p < 0.05. heat shock, hs.(E) Adult flies of the indicated genotypes were challenged with 
VSV. RT-qPCR of Tep II is shown, normalized to Rp49, and represented as relative to 
the uninfected mock-depleted controls. Mean ± SD of three independent experiments is 
shown; ∗p < 0.05.(F) Aedes aegypti Aag2 cells treated with the indicated dsRNAs were 
challenged with VSV (moi = 0.01) or SINV (moi = 0.5) and monitored by fluorescence 
microscopy (virus in green, nuclei in blue).(G) Quantification of images in (F) as 
normalized to controls is illustrated. Mean ± SD of three independent experiments is 
shown; ∗p < 0.05.(H) Northern blot analysis of Aag2 cells pretreated with the indicated 
dsRNAs and infected with either VSV or SINV is presented. See also Figure S5. (Fly 
husbandry and infections were performed by Beth Gordesky-Gold).  
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CHAPTER 3 – SUPPLEMENTAL FIGURES AND TABLES 
 
Figure S1. Transcriptional Pausing Pathway Components Restrict Viral Infection 
in Various Drosophila Cell Lines, Related to Figure 1. (A, B) Northern blot analysis of 
Drosophila cells treated with NELF-B and NELF-D for 3 days. Representative 
immunofluorescent images of (C) S2 cells or (D) Kc167 cells treated with the indicated 
dsRNAs and infected with VSV or SINV. (Virally infected cells are shown in green, nuclei 
in blue). 
 
	  57	  
 
Figure S2. Transcriptional Pausing Pathway Components Restrict Disparate 
Arboviruses, Related to Figure 2. (A) S2 or (B) Kc167 cells were treated with dsRNA 
against a control (Bgal) or Cdk9 (P-TEFb) and infected with the indicated viruses. 
Quantification of images as fold change in percentage of infected cells and normalized to 
controls. Mean ± S.D. of three independent experiments is shown; *p<0.05. (C) 
Drosophila cells were infected with either Kunjin (KUN), Rift Valley Fever Virus (RFV), or 
the natural fly pathogen Drosophila C Virus (DCV). Virally infected cells are shown in 
green, nuclei in blue. (D) Quantification of images in (C) as normalized to controls. Mean 
± S.D. of three technical replicates shown for a representative experiment. 
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Figure S3. Expression of Housekeeping Genes and PGN-Inducible DptB Are NELF 
and PTEFb-Independent, Related to Figure 5. (A) Basal levels of the indicated 
transcripts upon treatment with NELF-B, -D or Cdk9 dsRNAs, as measured by RT-
qPCR. Genes were normalized to Rp49 and defined as relative mRNA expression 
compared to control cells treated with Bgal dsRNAs. Mean ± S.D. of three independent 
experiments is shown; *p<0.05. (B) Drosophila cells were treated with the indicated 
dsRNAs and either untreated or treated with VSV (MOI = 10) or SINV (MOI-25) for 4 
hours. Delta CT values for Rp49 are shown. Mean ± S.D. of three independent 
experiments. (C) Drosophila cells were treated with the indicated dsRNAs and either 
untreated or treated with PGN for 6 hours. RT-qPCR of DptB was normalized as in (A). 
Mean ± S.D. of three independent experiments is shown; *p<0.005. 
	  59	  
 
 
Figure S4. Toll, Toll-2, and Toll-7 Exhibit the Chromatin Signature of 
Transcriptional Pausing, while PGN-Responsive Genes DptB and AttB Lack These 
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Features, Related to Figure 6. Mapping of Pol II (Rbp3), NELF (NELF-B), DSIF (Spt5), 
H3K4me3, and short RNA reads for (A) Toll (B) Toll-2 (18w) (C) Toll-7 (D) Toll-9 (E) 
DptB (F) AttB (G) Rp49 (H) Chc. Mapping of Pol II in the indicated cell types for (I) Tep II 
and (J) Toll. (K) GO enrichment of P-TEFb-dependent, VSV-induced genes with 
pausing-associated chromatin features. (p<0.05). (Reanalysis of genome-wide data was 
performed by Gregory Grant).  
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Figure S5. NELF-B and Cdk9 depletion in adult flies, related to Figure 7. Adult flies 
carrying heat-shock-inducible Gal4 were crossed to flies that can be induced to express 
dsRNA against either NELF-B (hs-Gal4 < UAS-NELF-B IR), Cdk9 (hs-Gal4 < UAS-Cdk9 
IR), or controls (hs- Gal4 < +) as indicated. Flies of the indicated genotype were 
monitored for efficient gene depletion upon heat shock by northern blotting for (A) NELF-
B and (B) Cdk9. (Fly husbandry were performed by Beth Gordesky-Gold). 
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Table S1A. Transcriptional profiling and enrichment analysis of VSV-infected 
Drosophila cells at 4 hours post-infection, related to Figure 3. Virally induced genes 
at 4 hours post-infection in Drosophila cells. Additional information is provided regarding 
each gene’s Cdk9-dependence, promoter-proximal enrichment of Pol II, NELF, DSIF, 
and short reads. (Bioinformatics analysis was performed by Gregory Grant). 
 
  
 
    
Gene 
Symbol 
Fold 
Change 
Cdk9-
Dependence 
RNA 
Pol II 
(Rpb3) 
NELF 
(NELF B) 
DSIF 
(Spt5) Short Reads 
moody 2.8 1 1 1 1 1 
18w 3.0 1 1 1 1 1 
mbc 4.7 1 1 1 1 1 
trio 4.4 1 1 1 1 1 
pyd 3.9 1 1 1 1 1 
CG30015 2.9 1 1 1 1 1 
ttk 2.9 1 1 1 1 1 
Dscam 3.1 1 1 1 1 1 
ImpL2 3.6 1 1 1 1 1 
Ten-m 3.2 1 1 1 1 1 
spir 3.0 1 1 1 1 1 
CG14995 3.0 1 1 1 1 1 
CG17838 2.9 1 1 1 1 1 
Ect4 3.5 1 1 1 1 1 
Top1 2.9 1 1 1 1 1 
Sulf1 3.7 1 1 1 1 1 
CG33298 3.3 1 1 1 1 1 
ph-p 3.8 1 1 1 1 1 
aop 3.1 1 1 1 1 1 
RhoGAP93
B 4.0 1 1 1 1 1 
puc 3.1 1 1 1 1 1 
Mmp1 2.9 1 1 1 1 1 
CG3409 3.5 1 1 1 1 1 
CG31012 2.8 1 1 1 1 1 
Cdep 2.8 1 1 1 1 1 
Tollo 3.4 1 1 1 1 1 
Apc 4.5 1 1 1 1 1 
glec 4.1 1 1 1 1 1 
siz 2.9 1 1 1 1 1 
sba 3.0 1 1 1 1 1 
CG16718 2.8 1 1 1 1 1 
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B52 3.9 1 1 1 1 1 
shn 3.5 1 1 1 1 1 
cbt 2.8 1 1 1 1 1 
CG3363 2.9 1 1 1 1 1 
ena 3.0 1 1 1 1 1 
CG7192 4.1 1 1 1 1 1 
Doa 3.3 1 1 1 1 1 
fray 3.0 1 1 1 1 1 
cp309 4.1 1 1 1 1 1 
CG34349 2.9 1 1 1 1 1 
ct 4.0 1 1 1 1 1 
fru 4.2 1 1 1 1 1 
l(1)G0148 4.2 1 1 1 1 1 
Fhos 3.2 1 1 1 1 1 
mbl 4.9 1 1 1 1 1 
norpA 2.9 1 1 1 1 1 
cno 6.2 1 1 1 1 1 
CG3973 2.9 1 1 1 1 1 
Not1 5.1 1 1 1 1 1 
Thd1 3.7 1 1 1 1 1 
l(1)G0196 5.4 1 1 1 1 1 
Pde8 3.5 1 1 1 1 1 
CG31158 3.9 1 1 1 1 1 
shi 3.4 1 1 1 1 1 
CG8026 3.1 1 1 1 1 1 
RpII215 3.0 1 1 1 1 1 
dom 3.2 1 1 1 1 1 
dlg1 3.6 1 1 1 1 1 
AGO1 4.1 1 1 1 1 1 
CG8924 3.0 1 1 1 1 1 
A3-3 6.4 1 1 1 1 1 
mask 4.5 1 1 1 1 1 
CG11033 3.0 1 1 1 1 1 
mura 3.3 1 1 1 1 1 
arr 3.7 1 1 1 1 1 
spen 2.8 1 1 1 1 1 
kis 3.1 1 1 1 1 1 
zfh1 4.3 1 1 1 1 1 
CG10011 2.8 1 1 1 1 1 
CycT 4.5 1 1 1 1 1 
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CG11486 3.1 1 1 1 1 1 
Mef2 2.9 1 1 1 1 1 
S 3.5 1 1 1 1 1 
Nup153 3.8 1 1 1 1 1 
nmo 2.9 1 1 1 1 1 
CG31531 3.9 1 1 1 1 1 
fwd 4.4 1 1 1 1 1 
sdk 4.3 1 1 1 1 1 
CG32138 2.8 1 1 1 1 1 
ush 3.6 1 1 1 1 1 
CG15609 2.8 1 1 1 1 1 
Asx 3.8 1 1 1 1 1 
CG18812 2.8 1 1 1 1 1 
CG31224 4.1 1 1 1 1 1 
CG31048 3.0 1 1 1 1 1 
cnk 3.1 1 1 1 1 1 
MESR4 5.0 1 1 1 1 1 
csw 3.6 1 1 1 1 1 
CG30497 2.9 1 1 1 1 1 
CG4294 2.9 1 1 1 1 1 
east 3.2 1 1 1 1 1 
ps 4.4 1 1 1 1 1 
chb 3.3 1 1 1 1 1 
Nhe3 3.6 1 1 1 1 1 
CG34413 5.0 1 1 1 1 1 
CG14073 3.7 1 1 1 1 1 
CG2924 3.4 1 1 1 1 1 
gpp 5.8 1 1 1 1 1 
Rel 2.9 1 1 1 1 1 
CG4272 3.2 1 1 1 1 1 
CG3287 2.9 1 1 1 1 1 
bon 3.1 1 1 1 1 1 
glo 2.9 1 1 1 1 1 
Pka-C1 3.1 1 1 1 1 1 
sgg 3.7 1 1 1 1 1 
pum 3.2 1 1 1 1 1 
CG8965 3.4 1 0 1 1 1 
Rapgap1 4.2 1 0 1 1 1 
sda 2.8 1 0 1 1 1 
trol 4.2 1 0 1 1 1 
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chif 2.9 1 1 1 1 0 
Vrp1 4.2 1 1 0 1 1 
sprt 3.6 1 0 1 1 1 
Glycogenin 2.8 1 1 1 0 1 
CG5245 3.4 1 1 0 1 1 
heph 3.0 1 0 1 1 1 
sm 3.2 1 0 1 1 1 
yrt 3.3 1 0 1 1 1 
Kr-h1 2.8 1 1 1 0 1 
DLP 3.0 1 0 1 1 1 
trx 3.4 1 1 1 1 0 
CG10631 3.9 1 0 1 1 1 
CG13531 4.0 1 1 0 1 1 
Pdk 3.3 1 0 1 1 1 
Atx2 3.3 1 1 1 0 1 
Cbl 6.3 1 1 1 1 0 
CG30389 3.5 1 0 1 1 1 
prominin-
like 3.2 1 1 0 1 1 
CG8334 3.2 1 1 0 1 1 
disco 4.5 1 1 1 0 0 
CG14879 2.9 1 1 0 0 1 
Ca-P60A 2.9 1 1 0 0 1 
CG5098 5.0 1 1 0 0 1 
del 2.9 1 1 0 0 1 
hop 3.1 1 1 0 0 1 
CG10462 3.6 1 1 0 0 1 
CG10979 3.4 1 1 0 0 1 
Cbp80 3.8 1 1 0 0 1 
tou 3.9 1 1 0 0 1 
pod1 3.2 1 1 0 0 1 
CG5522 3.0 1 1 0 0 1 
tud 3.8 1 0 0 1 1 
CG6945 4.1 1 1 0 0 1 
Socs16D 3.4 1 1 0 0 1 
stau 4.0 1 1 0 1 0 
CG2926 5.2 1 1 0 0 1 
CG7177 4.9 1 1 0 0 1 
lap 3.0 1 1 0 1 0 
robo 3.5 1 0 1 0 1 
bves 4.7 1 1 0 0 1 
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Aac11 2.9 1 1 0 0 1 
ttv 3.0 1 1 0 0 1 
CG5524 3.5 1 0 1 0 1 
Smox 3.7 1 1 0 0 1 
Bruce 4.3 1 0 1 0 1 
CG31998 3.6 1 1 0 0 1 
pgant5 2.8 1 0 1 1 0 
CG14440 3.2 1 1 0 0 1 
tws 3.5 1 1 0 0 1 
CG16896 2.8 1 1 0 0 1 
Exp6 3.4 1 1 0 0 1 
NAT1 2.9 1 1 0 0 1 
Cp190 3.1 1 1 0 0 1 
drl 3.1 1 0 0 0 1 
Ptp99A 2.8 1 0 0 0 1 
CG14183 3.5 1 0 0 0 1 
CG30484 3.6 1 0 0 0 1 
CG6923 6.4 1 0 0 0 1 
bol 2.9 1 0 0 0 1 
CG5514 3.3 1 0 0 0 1 
en 4.5 1 0 0 0 1 
capu 3.0 1 0 0 0 1 
CG15099 3.7 1 1 0 0 0 
CG32306 3.0 1 0 0 0 1 
CG11353 4.7 1 0 0 0 1 
CG18628 3.2 1 0 0 0 1 
asl 3.3 1 1 0 0 0 
CG11983 4.1 1 0 0 0 1 
CG11448 4.0 1 0 0 0 1 
CG3860 3.0 1 0 0 0 1 
CG40351 3.0 1 0 0 0 1 
ana1 3.5 1 0 0 0 1 
Sbf 3.5 1 0 0 0 1 
Spc105R 3.4 1 0 0 0 1 
CG8552 3.4 1 1 0 0 0 
CG32809 3.4 1 0 0 0 1 
CG31612 3.1 1 0 1 0 0 
CG4841 4.2 1 0 0 0 1 
CG11376 2.9 1 0 0 0 1 
mud 4.1 1 0 0 0 1 
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CG2249 3.4 1 1 0 0 0 
CG4589 3.0 1 0 0 0 1 
CG32113 3.1 1 0 0 0 1 
enok 4.8 1 0 0 0 1 
CG31064 3.3 1 0 0 0 1 
CG8195 3.1 1 0 0 0 1 
bchs 2.9 1 1 0 0 0 
CG3984 3.0 1 0 0 0 1 
Camta 5.4 1 0 0 0 1 
chp 3.0 1 0 0 0 1 
CG30007 3.3 1 0 0 0 1 
CG16742 3.1 1 0 0 0 1 
CG10492 3.4 1 1 0 0 0 
seq 3.1 1 0 0 0 1 
CG7376 5.0 1 0 0 0 1 
Dhc64C 3.1 1 1 0 0 0 
CG12734 3.6 1 1 0 0 0 
CG16777 4.3 1 0 0 0 1 
Bub1 3.0 1 0 0 1 0 
CG10445 3.1 1 1 0 0 0 
Ca-alpha1D 3.4 1 0 0 0 1 
CG18596 3.0 1 0 0 0 1 
vav 2.8 1 0 0 0 1 
CG12121 2.8 1 0 0 0 1 
gfzf 2.9 1 1 0 0 0 
CG7220 3.7 1 0 0 0 1 
CG34133 4.2 1 0 0 0 1 
CG32458 3.0 1 0 0 0 1 
CG4783 3.3 1 0 0 0 1 
CG7843 2.8 1 0 0 0 1 
msl-1 3.1 1 0 0 0 1 
sl 3.0 1 0 0 0 1 
Stam 3.1 1 1 0 0 0 
CG11307 2.9 1 0 0 0 1 
Ge-1 2.9 1 1 0 0 0 
crb 4.6 1 0 0 0 0 
CG34234 2.9 1 0 0 0 0 
Zasp 3.0 1 0 0 0 0 
Fas3 3.2 1 0 0 0 0 
dy 6.3 1 0 0 0 0 
CG31510 3.6 1 0 0 0 0 
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Cad96Ca 2.9 1 0 0 0 0 
CG5629 3.5 1 0 0 0 0 
Cad87A 3.7 1 0 0 0 0 
CG32719 5.4 1 0 0 0 0 
CG32108 2.8 1 0 0 0 0 
CG10283 3.0 1 0 0 0 0 
cngl 2.9 1 0 0 0 0 
CG31846 4.2 1 0 0 0 0 
Cenp-C 3.6 1 0 0 0 0 
CG31847 4.6 1 0 0 0 0 
br 3.7 1 0 0 0 0 
CG9311 3.4 1 0 0 0 0 
CG31367 3.8 1 0 0 0 0 
CG2519 3.8 1 0 0 0 0 
unc-104 4.8 1 0 0 0 0 
NaCP60E 3.3 1 0 0 0 0 
CG3679 3.3 1 0 0 0 0 
CG11166 4.0 1 0 0 0 0 
H 6.7 1 0 0 0 0 
CG1815 5.0 1 0 0 0 0 
CG18604 3.4 1 0 0 0 0 
CG32681 4.0 1 0 0 0 0 
CG8290 3.1 1 0 0 0 0 
ald 3.3 1 0 0 0 0 
CG5151 3.7 1 0 0 0 0 
CG3654 3.6 1 0 0 0 0 
CG10348 3.5 1 0 0 0 0 
CG5262 4.6 1 0 0 0 0 
Nos 6.4 1 0 0 0 0 
CG9044 3.1 1 0 0 0 0 
E(bx) 3.3 1 0 0 0 0 
CG13362 2.9 1 0 0 0 0 
gt 3.6 1 0 0 0 0 
cic 4.6 1 0 0 0 0 
CG30020 3.8 1 0 0 0 0 
CG17724 3.1 1 0 0 0 0 
CG14998 2.8 1 0 0 0 0 
fat2 3.0 1 0 0 0 0 
CG13894 7.2 1 0 0 0 0 
CG11265 3.0 1 0 0 0 0 
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fs(1)h 3.4 1 0 0 0 0 
Lap1 3.4 1 0 0 0 0 
Spindly 3.1 1 0 0 0 0 
CG14562 3.9 1 0 0 0 0 
CG10948 3.2 1 0 0 0 0 
cpo 3.1 1 0 0 0 0 
RhoGAP19
D 3.0 1 0 0 0 0 
CG11873 4.2 0 1 1 1 1 
Su(var)2-
HP2 3.1 0 0 0 0 0 
CG13322 3.0 0 1 1 0 0 
rdgA 6.6 0 0 0 0 0 
ari-2 2.8 0 1 1 1 1 
RN-tre 2.8 0 1 1 1 1 
X11L 3.0 0 1 0 0 1 
CG42232 5.2 0 1 0 0 1 
Pcl 3.8 0 0 0 0 0 
CG10801 3.1 0 0 0 0 0 
Suv4-20 3.3 0 1 1 1 1 
Tao-1 3.2 0 1 1 1 1 
CG16972 3.1 0 1 1 1 0 
CG15398 6.4 0 0 0 0 0 
CadN 7.1 0 0 0 0 0 
CG5630 3.2 0 0 1 1 1 
CG13716 3.6 0 0 0 0 0 
egh 2.9 0 1 1 0 1 
CG13679 2.9 0 0 0 0 0 
chinmo 3.4 0 1 1 1 1 
CG12689 9.3 0 0 0 0 0 
CG32235 3.4 0 0 0 0 0 
CG13325 5.3 0 0 0 0 0 
CG11413 3.6 0 0 0 0 0 
CG5968 4.3 0 0 0 0 0 
CG12250 3.3 0 0 0 0 0 
mld 4.8 0 1 1 1 1 
Aly 2.8 0 0 0 0 1 
CG42246 3.2 0 0 0 0 0 
CG13800 3.3 0 1 1 1 1 
rno 4.1 0 0 0 0 1 
CG9715 4.0 0 1 1 1 0 
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SRPK 4.1 0 1 1 1 1 
DIP1 4.3 0 1 0 1 1 
Mbs 5.0 0 1 1 1 1 
CG8944 3.3 0 1 0 1 1 
Hmr 4.7 0 0 0 0 1 
Aef1 4.9 0 1 1 1 1 
hep 4.0 0 1 1 0 1 
CG4877 2.8 0 0 1 0 1 
CG7053 2.9 0 0 0 0 0 
Bap170 3.2 0 0 0 0 1 
CG12717 3.3 0 0 0 0 0 
Lar 3.7 0 0 0 0 1 
Nf1 3.7 0 0 0 0 0 
Ac76E 3.0 0 0 1 1 1 
Gug 3.8 0 1 1 0 1 
Dab 5.1 0 0 0 0 1 
TORC 3.1 0 0 1 0 1 
CG7457 3.1 0 0 0 0 0 
DIP2 3.4 0 0 0 0 1 
CG8092 4.1 0 0 0 0 0 
Nup154 2.8 0 1 0 0 1 
CG1951 3.3 0 0 0 0 0 
CG6734 2.8 0 0 0 0 0 
CG6701 4.2 0 1 0 0 1 
CG14741 7.4 0 0 0 0 1 
CG1647 3.5 0 0 0 0 0 
CG11902 4.4 0 0 0 0 1 
CG16782 4.8 0 0 0 0 0 
Gr36c 3.2 0 0 0 0 0 
CG14478 4.2 0 1 1 1 1 
pr-set7 4.1 0 1 0 1 0 
tefu 3.1 0 1 1 1 1 
PhKgamma 3.4 0 1 0 0 1 
Lasp 2.9 0 1 1 1 1 
hdc 2.9 0 0 0 0 0 
CG12159 3.0 0 1 0 0 1 
CG32210 3.1 0 1 1 1 1 
CG17090 3.3 0 0 0 0 0 
Khc-73 2.8 0 1 1 1 1 
CG17786 5.4 0 0 0 0 0 
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CG9003 3.0 0 0 1 0 0 
skd 6.5 0 1 1 1 1 
Usf 3.3 0 0 0 0 1 
babo 3.3 0 1 1 1 1 
CG31122 4.2 0 1 0 1 1 
CG3655 3.0 0 0 1 1 1 
CG2941 3.1 0 0 0 0 1 
Fur1 3.0 0 1 1 1 1 
l(2)k09022 2.9 0 0 0 0 0 
pan 5.4 0 0 0 0 0 
CG14438 2.9 0 1 1 1 1 
CG6700 3.3 0 1 1 1 1 
LIMK1 4.3 0 0 0 0 1 
5-HT1B 5.6 0 0 0 0 0 
CG7466 3.3 0 0 0 0 0 
Mys45A 3.0 0 0 0 0 1 
CG6509 2.9 0 0 0 0 1 
CG30169 3.3 0 0 0 0 0 
CG33095 3.2 0 0 0 0 1 
CG16940 3.4 0 1 1 0 1 
sec24 4.2 0 1 0 0 0 
stumps 3.3 0 0 0 0 0 
Cpr64Ad 3.6 0 0 0 0 0 
CG1718 3.3 0 0 0 0 0 
ire-1 3.3 0 1 1 1 1 
Cyp313a5 3.2 0 0 0 0 0 
faf 3.9 0 1 0 0 1 
ken 3.6 0 1 1 1 1 
l(1)G0156 3.2 0 1 1 1 1 
CG8771 3.5 0 0 0 0 0 
CG9902 4.0 0 0 0 0 1 
shot 3.4 0 1 1 1 1 
CG13029 5.7 0 0 0 0 0 
CG8233 3.2 0 0 0 0 0 
CG11360 4.3 0 1 1 1 0 
CG31388 3.8 0 0 0 0 0 
CG3376 2.8 0 1 1 1 1 
pad 3.1 0 1 1 1 1 
CG17836 3.7 0 0 0 0 0 
Msp-300 3.1 0 1 1 1 1 
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CG31961 2.9 0 0 0 0 1 
CG5146 2.9 0 0 0 0 1 
CG7971 3.0 0 0 0 0 1 
CG33330 3.8 0 0 0 0 0 
CG30394 4.0 0 1 1 1 1 
CG8343 3.1 0 0 0 0 0 
lid 3.7 0 1 0 1 1 
CG7337 3.5 0 1 1 1 1 
CG40239 3.0 0 0 0 0 0 
CG5674 2.9 0 0 0 0 0 
RpL12 2.8 0 1 0 1 1 
Pez 4.1 0 1 1 1 0 
Egfr 3.4 0 0 0 0 1 
CG10804 7.5 0 0 0 0 0 
PTP-ER 3.2 0 0 0 0 1 
CG5205 5.0 0 0 0 0 1 
CG2097 3.0 0 0 0 0 0 
mus210 3.2 0 0 0 0 0 
CG5720 3.0 0 1 0 0 1 
Pc 2.8 0 0 1 0 1 
slik 3.9 0 1 1 1 0 
emp 3.0 0 0 0 0 1 
CG34126 3.2 0 0 1 0 1 
CG10077 3.1 0 1 0 0 1 
pcx 4.5 0 0 0 0 1 
Su(var)2-10 3.4 0 0 0 0 0 
zip 3.0 0 1 1 1 1 
gft 3.0 0 0 0 0 0 
brm 3.1 0 1 0 0 0 
HLHmdelta 3.7 0 0 0 0 0 
mu2 3.0 0 0 0 0 0 
CG16711 3.0 0 0 0 0 1 
Gprk2 2.9 0 1 1 1 1 
sano 3.0 0 0 0 0 0 
CG4612 3.1 0 1 1 1 1 
sbr 2.9 0 1 0 0 1 
CG10414 2.9 0 0 0 0 0 
Cyp12a4 2.8 0 0 0 0 0 
wit 3.5 0 0 0 0 0 
Tsp 3.3 0 1 1 1 1 
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Gr36d 6.4 0 0 0 0 0 
MICAL 3.2 0 1 1 1 1 
nbs 3.6 0 0 0 0 1 
CG10543 4.4 0 1 0 1 1 
Snm1 2.9 0 0 0 0 1 
mnb 2.8 0 1 1 1 1 
Ced-12 3.1 0 0 0 0 0 
Dcr-2 3.1 0 0 0 0 0 
CG3605 2.9 0 0 0 0 0 
CG9461 3.2 0 1 1 1 0 
CG13084 3.0 0 0 0 0 0 
Syn 5.6 0 0 0 0 0 
CG11321 3.5 0 0 0 0 0 
CG30069 3.8 0 0 0 0 1 
Gr36a 4.8 0 0 0 0 0 
lrrk 2.9 0 0 0 0 0 
CG1347 3.4 0 1 1 1 1 
scrib 2.8 0 1 1 1 1 
CG30047 3.2 0 0 0 0 1 
Tango13 2.9 0 0 0 0 1 
bs 3.4 0 0 0 0 1 
Hil 3.0 0 1 1 1 1 
CG9339 3.0 0 1 1 1 1 
CG14450 2.9 0 1 1 1 1 
Mgat1 3.2 0 0 0 0 1 
sick 2.8 0 1 1 1 1 
CG42248 3.7 0 0 0 0 0 
Pi3K92E 3.5 0 1 0 0 0 
Su(H) 2.8 0 0 0 0 0 
CG32532 4.4 0 0 0 0 0 
CYLD 3.2 0 0 0 0 1 
beat-Ib 8.0 0 0 0 0 0 
CG5467 3.3 0 0 0 0 0 
CG5348 4.4 0 0 0 0 0 
wge 2.9 0 1 0 0 1 
slpr 2.9 0 0 0 0 1 
CG4049 5.2 0 0 0 0 1 
CG12316 3.4 0 0 0 0 1 
tho2 3.1 0 0 0 0 1 
NELF-A 3.3 0 1 1 1 1 
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lola 3.5 0 1 1 1 1 
CG17856 4.6 0 0 0 0 0 
CG8786 3.6 0 0 0 0 0 
CG10600 6.0 0 1 0 0 1 
CG14619 3.5 0 1 1 1 1 
Gr36b 6.0 0 0 0 0 0 
Tie 4.9 0 0 0 0 0 
CG13602 4.1 0 1 0 0 1 
CG5794 8.0 0 1 0 0 1 
CG15461 3.8 0 0 0 0 0 
CG34401 3.3 0 1 1 1 1 
CG13424 3.4 0 0 0 0 0 
CG11727 3.2 0 0 1 0 1 
jing 3.2 0 0 0 0 1 
D2R 6.9 0 0 0 0 0 
Axn 2.8 0 0 0 0 1 
Itp-r83A 4.0 0 1 1 1 1 
disp 2.9 0 0 0 0 1 
Sos 3.0 0 0 0 0 0 
CG5174 2.9 0 1 0 0 1 
GATAd 3.3 0 1 0 0 1 
Als 2.8 0 0 0 0 0 
ash1 6.6 0 1 1 0 1 
CG7922 4.8 0 0 0 0 0 
muskelin 3.7 0 0 0 0 1 
Pkn 7.5 0 1 1 1 1 
Chd3 2.9 0 1 0 0 1 
Nak 3.7 0 0 0 0 1 
CG4854 4.0 0 0 0 0 0 
mtTFB2 3.5 0 0 0 0 1 
CG33097 3.2 0 0 0 0 1 
CG12236 3.6 0 0 0 0 0 
CG31368 3.0 0 0 0 0 0 
CG1531 3.3 0 0 0 0 0 
CG33324 3.8 0 0 0 0 0 
E(Pc) 2.9 0 1 1 1 1 
CG8405 3.0 0 0 0 0 0 
CG3338 3.3 0 0 0 0 0 
CG7692 3.4 0 0 0 0 1 
CG14662 4.0 0 0 0 0 0 
	  75	  
CG8177 4.5 0 0 1 1 1 
ear 3.0 0 0 0 0 0 
CG12662 3.6 0 0 0 0 0 
CG32088 3.1 0 0 0 0 1 
CG10188 2.8 0 1 0 0 0 
CG17806 3.0 0 0 0 0 0 
Sin3A 4.0 0 1 1 1 1 
CG30460 3.6 0 0 0 0 1 
tra 2.8 0 0 0 0 1 
CG4751 2.9 0 0 0 0 1 
CG33967 5.6 0 1 1 1 1 
CG32698 4.5 0 0 0 0 0 
CG14023 4.8 0 1 1 1 1 
CG17612 3.6 0 0 0 0 0 
p130CAS 3.2 0 1 1 1 1 
CG17078 3.8 0 1 1 1 1 
CG9425 3.1 0 1 0 0 1 
l(3)L1231 3.2 0 1 1 1 0 
CG17233 3.1 0 1 1 1 1 
Ugt37c1 3.0 0 0 0 0 0 
CG14915 5.4 0 0 0 0 0 
pps 5.2 0 0 0 0 0 
Abi 3.4 0 1 0 0 1 
Mrtf 4.1 0 0 0 1 1 
CG18537 3.9 0 0 0 0 0 
CG32726 3.5 0 0 0 0 0 
CG9254 3.0 0 0 0 0 1 
kay 3.3 0 1 1 1 1 
CG32133 3.5 0 0 0 0 0 
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Table S1B. Transcriptional profiling and enrichment analysis of VSV-infected 
Drosophila cells at 4 hours post-infection, related to Figure 3.  Genes that are 
downregulated after 4 hours post-infection in Drosophila cells. 
 
Gene 
Name 
Fold 
Change 
	  
Gene 
Name 
Fold 
Change 
	  
Gene 
Name 
Fold 
Change 
CG10165 0.3 
	  
Pgant35A 0.4 
	  
alpha-Est3 0.3 
CG6934 0.3 
	  
CG3149 0.4 
	  
CG4726 0.3 
CG17292 0.3 
	  
CG13559 0.3 
	  
snRNP70K 0.3 
CG5707 0.3 
	  
stil 0.3 
	  
CG30403 0.3 
CG6287 0.3 
	  
CG14511 0.4 
	  
CG2709 0.3 
CG18522 0.3 
	  
CG4140 0.3 
	  
Rab27 0.3 
Gpdh 0.3 
	  
CG18643 0.3 
	  
Eip71CD 0.2 
O-fut2 0.3 
	  
CG11679 0.3 
	  
CG3770 0.3 
Snoo 0.3 
	  
CG14786 0.3 
	  
CG15172 0.3 
CG18547 0.3 
	  
CG32259 0.3 
	  
CG1827 0.3 
CG5224 0.3 
	  
mRpL36 0.3 
	  
Lsm10 0.3 
CG6126 0.3 
	  
CG13018 0.3 
	  
CG8586 0.3 
Hsp70Bc 0.1 
	  
CG8862 0.3 
	  
CG4404 0.3 
CG11899 0.3 
	  
CG1971 0.3 
	  
cid 0.4 
CG8306 0.3 
	  
CG17726 0.4 
	  
CG5321 0.3 
CG11501 0.3 
	  
CG13732 0.3 
	  
CG14430 0.3 
Sirt4 0.3 
	  
CG12320 0.3 
	  
CG13563 0.3 
Fdh 0.4 
	  
CG3184 0.3 
	  
Nep2 0.3 
CG12214 0.3 
	  
CG9706 0.3 
	  
Cpr50Cb 0.3 
CG5254 0.3 
	  
hd 0.4 
	  
CG3603 0.3 
Hsp68 0.3 
	  
CG5167 0.3 
	  
CG3397 0.2 
l(2)01810 0.3 
	  
CG31950 0.3 
	  
CG4630 0.3 
CG8021 0.2 
	  
CG1753 0.4 
	  
CG14523 0.2 
CG17207 0.3 
	  
CG17036 0.3 
	  
Gip 0.3 
regucalcin 0.3 
	  
CG4797 0.4 
	  
CG13117 0.2 
CG30414 0.3 
	  
CG7322 0.3 
	  
agt 0.3 
CG14544 0.3 
	  
hdm 0.3 
	  
CG9547 0.3 
Reg-2 0.4 
	  
CG31549 0.3 
	  
CG7458 0.3 
CG5590 0.3 
	  
CG6329 0.3 
	  
CG9149 0.4 
CG4365 0.3 
	  
CG14935 0.3 
	  
fbp 0.4 
CG9542 0.3 
	  
CG15766 0.3 
	  
CG13218 0.3 
Dbi 0.3 
	  
CG32187 0.3 
	  
CG13227 0.3 
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Table S1C. Transcriptional profiling and enrichment analysis of VSV-infected 
Drosophila cells at 4 hours post-infection, related to Figure 3.  List of GO Terms for 
virally-induced genes and their associated genes. 
GO	  Terms	   P-­‐value	   Number	  of	  Genes	   Gene	  Probe	  IDs	  
Humoral	  Immune	  
Response	   2.4E-­‐02	   8	  
1628262_A_AT,	  1636513_A_AT,	  
1636185_AT,	  1635096_AT,	  
1627376_AT,	  1626509_AT,	  
1641226_A_AT,	  1625113_S_AT	  
Immune	  system	  
development	   1.0E-­‐02	   8	  
1625243_A_AT,	  1628262_A_AT,	  
1639072_AT,	  1629921_A_AT,	  
1636831_S_AT,	  1627362_A_AT,	  
1636034_AT,	  1632698_AT	  
RNA	  interference	   3.7E-­‐02	   5	  
1632602_S_AT,	  1629307_S_AT,	  
1636949_S_AT,	  1641449_AT,	  
1636071_A_AT	  
Autophagic	  cell	  
death	   7.9E-­‐03	   9	  
1637312_A_AT,	  1627840_A_AT,	  
1639411_AT,	  1625761_A_AT,	  
1623605_A_AT,	  1625196_A_AT,	  
1624361_S_AT,	  1640892_A_AT,	  
1636991_S_AT	  
Jak-­‐STAT	  signaling	   3.3E-­‐06	   8	  
1625775_A_AT,	  1639072_AT,	  
1635260_AT,	  1627362_A_AT,	  
1631594_S_AT,	  1633335_AT,	  
1635580_AT,	  1636122_AT	  
Protein	  tyrosine	  
phosphatase	  
activity	  
1.5E-­‐02	   7	  
1625775_A_AT,	  1635842_AT,	  
1631765_AT,	  1629795_AT,	  
1623837_AT,	  1637537_AT,	  
1632003_A_AT	  
MAPK	  signaling	  
pathway	   2.9E-­‐02	   4	  
1625775_A_AT,	  1627394_S_AT,	  
1633948_A_AT,	  1633335_AT	  
MAPKKK	  cascade	   4.6E-­‐04	   9	  
1632618_A_AT,	  1637966_AT,	  
1627394_S_AT,	  1623605_A_AT,	  
1631765_AT,	  1636185_AT,	  
1629795_AT,	  1637322_AT,	  
1623804_A_AT	  
Regulation	  of	  Ras	  
protein	  signal	  
transduction	  
2.5E-­‐05	   14	  
1627394_S_AT,	  1635047_S_AT,	  
1633757_S_AT,	  1633026_A_AT,	  
1626591_AT,	  1631094_S_AT,	  
1633335_AT,	  1635592_AT,	  
1632945_AT,	  1638352_AT,	  
1638996_AT,	  1636023_AT,	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1628651_A_AT,	  1622996_AT	  
Protein	  tyrosine	  
kinase	  activity	   7.2E-­‐03	   9	  
1629129_AT,	  1637966_AT,	  
1639072_AT,	  1641452_A_AT,	  
1633948_A_AT,	  1623418_AT,	  
1623804_A_AT,	  1640892_A_AT,	  
1624297_AT	  
Chromatin	  
remodeling	   6.3E-­‐04	   9	  
1625243_A_AT,	  1627796_S_AT,	  
1624533_S_AT,	  1636831_S_AT,	  
1636034_AT,	  1637356_A_AT,	  
1629321_AT,	  1640433_A_AT,	  
1635854_S_AT	  
SNF2-­‐related	   7.3E-­‐05	   7	  
1631735_AT,	  1623124_AT,	  
1636513_A_AT,	  1636831_S_AT,	  
1630786_AT,	  1623343_AT,	  
1636034_AT	  
Regulation	  of	  cell	  
cycle	   6.8E-­‐06	   22	  
1623383_AT,	  1624941_AT,	  
1624021_A_AT,	  1636185_AT,	  
1639806_AT,	  1629290_AT,	  
1623424_A_AT,	  1630729_AT,	  
1626892_AT,	  1633335_AT,	  
1632418_S_AT,	  1629921_A_AT,	  
1634509_S_AT,	  1631765_AT,	  
1633948_A_AT,	  1628903_S_AT,	  
1637781_AT,	  1633501_S_AT,	  
1623237_AT,	  1624463_S_AT,	  
1623179_AT,	  1623274_S_AT	  
Response	  to	  
ecdysone	   1.5E-­‐02	   5	  
1637312_A_AT,	  1627840_A_AT,	  
1625243_A_AT,	  1623441_AT,	  
1631481_A_AT	  
Calcium-­‐
dependent	  cell-­‐
cell	  adhesion	  
1.1E-­‐02	   5	  
1633000_A_AT,	  1641473_AT,	  
1623418_AT,	  1641575_AT,	  
1627761_AT	  
Cell	  projection	   6.5E-­‐03	   12	  
1632196_AT,	  1624021_A_AT,	  
1636378_A_AT,	  1625761_A_AT,	  
1631013_AT,	  1639806_AT,	  
1632057_AT,	  1637619_S_AT,	  
1623984_S_AT,	  1628548_AT,	  
1627191_A_AT,	  1636576_S_AT	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Epithelial	  cell	  
migration	   3.3E-­‐02	   5	  
1625775_A_AT,	  1635260_AT,	  
1626774_S_AT,	  1634063_A_AT,	  
1628859_AT	  
Establishment	  or	  
maintenance	  of	  
polarity	  of	  
follicular	  
epithelium	  
7.4E-­‐04	   6	  
1628146_AT,	  1624021_A_AT,	  
1625775_A_AT,	  1631621_S_AT,	  
1633948_A_AT,	  1635580_AT	  
Cell	  junction	   1.3E-­‐03	   15	  
1633000_A_AT,	  1624021_A_AT,	  
1630794_AT,	  1628146_AT,	  
1632618_A_AT,	  1636378_A_AT,	  
1633745_A_AT,	  1639189_AT,	  
1639928_A_AT,	  1637322_AT,	  
1627191_A_AT,	  1629115_S_AT,	  
1641473_AT,	  1632207_A_AT,	  
1641490_S_AT	  
Regulation	  of	  cell	  
development	   4.3E-­‐04	   16	  
1633000_A_AT,	  1624021_A_AT,	  
1628319_S_AT,	  1635047_S_AT,	  
1627394_S_AT,	  1641452_A_AT,	  
1633745_A_AT,	  1631055_AT,	  
1636576_S_AT,	  1632418_S_AT,	  
1625775_A_AT,	  1633016_A_AT,	  
1633948_A_AT,	  1630456_AT,	  
1626518_AT,	  1628548_AT	  
Negative	  
regulation	  of	  Wnt	  
receptor	  signaling	  
pathway	  
9.1E-­‐03	   5	  
1625636_S_AT,	  1632134_S_AT,	  
1624300_S_AT,	  1628548_AT,	  
1623084_AT	  
Regulation	  of	  cell	  
size	   1.4E-­‐02	   9	  
1633000_A_AT,	  1632618_A_AT,	  
1637966_AT,	  1628651_A_AT,	  
1631594_S_AT,	  1623804_A_AT,	  
1635909_AT,	  1637619_S_AT,	  
1626518_AT	  
Apical	  part	  of	  cell	   7.5E-­‐04	   9	  
1627840_A_AT,	  1628146_AT,	  
1624021_A_AT,	  1633016_A_AT,	  
1632784_AT,	  1626073_A_AT,	  
1630887_A_AT,	  1628548_AT,	  
1640092_A_AT	  
Adherens	  
junction	   6.4E-­‐04	   9	  
1628146_AT,	  1632618_A_AT,	  
1632207_A_AT,	  1633745_A_AT,	  
1639189_AT,	  1639928_A_AT,	  
1637322_AT,	  1627191_A_AT,	  
1641490_S_AT	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Regulation	  of	  
cytoskeleton	  
organization	  
1.1E-­‐03	   9	  
1623383_AT,	  1634509_S_AT,	  
1633745_A_AT,	  1639806_AT,	  
1640968_A_AT,	  1628859_AT,	  
1627191_A_AT,	  1626892_AT,	  
1631940_S_AT	  
Imaginal	  disc	  
pattern	  formation	   4.9E-­‐05	   15	  
1627445_S_AT,	  1626376_AT,	  
1637206_AT,	  1635909_AT,	  
1625445_S_AT,	  1631055_AT,	  
1628759_A_AT,	  1638568_S_AT,	  
1629921_A_AT,	  1623605_A_AT,	  
1633948_A_AT,	  1633501_S_AT,	  
1630269_S_AT,	  1636066_S_AT,	  
1628548_AT	  
Sex	  
differentiation	   3.7E-­‐03	   9	  
1637312_A_AT,	  1626806_AT,	  
1627445_S_AT,	  1637966_AT,	  
1628262_A_AT,	  1631498_A_AT,	  
1640892_A_AT,	  1625385_AT,	  
1628840_AT	  
Learning	  or	  
memory	   3.8E-­‐04	   12	  
1632418_S_AT,	  1632380_AT,	  
1627673_AT,	  1641473_AT,	  
1633016_A_AT,	  1628651_A_AT,	  
1628859_AT,	  1624297_AT,	  
1625445_S_AT,	  1631055_AT,	  
1627248_AT,	  1623084_AT	  
Cell	  recognition	   3.8E-­‐05	   11	  
1633000_A_AT,	  1641473_AT,	  
1630004_AT,	  1632207_A_AT,	  
1635096_AT,	  1633745_A_AT,	  
1626099_S_AT,	  1626774_S_AT,	  
1637619_S_AT,	  1624297_AT,	  
1632003_A_AT	  
Positive	  
regulation	  of	  
nitrogen	  
compound	  
metabolic	  process	  
6.0E-­‐04	   15	  
1627796_S_AT,	  1633855_S_AT,	  
1636679_AT,	  1635096_AT,	  
1639940_AT,	  1629321_AT,	  
1639947_S_AT,	  1628423_AT,	  
1626232_AT,	  1623605_A_AT,	  
1624533_S_AT,	  1629921_A_AT,	  
1636831_S_AT,	  1630023_AT,	  
1627376_AT	  
Neuromuscular	  
process	   2.4E-­‐02	   4	  
1636673_S_AT,	  1635096_AT,	  
1626774_S_AT,	  1640892_A_AT	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Muscle	  cell	  
differentiation	   1.2E-­‐05	   14	  
1632196_AT,	  1640409_AT,	  
1627394_S_AT,	  1641452_A_AT,	  
1637684_AT,	  1623984_S_AT,	  
1626591_AT,	  1637312_A_AT,	  
1627840_A_AT,	  1633948_A_AT,	  
1631013_AT,	  1634562_S_AT,	  
1628385_A_AT,	  1623084_AT	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Table S1D. Transcriptional profiling and enrichment analysis of VSV-infected 
Drosophila cells at 4 hours post-infection, related to Figure 3.  Virally-induced genes 
at 4 hours post-infection in Drosophila cells that have been annotated to have 
immunologic function by GO analysis. 
Gene Name Fold Induction Terms 
Nos 6.4 GO:0006952~defense	  response	  
CYLD 3.2 
GO:0006952~defense	  
response,GO:0009617~response	  to	  bacterium	  
Dscam 3.1 
GO:0006909~phagocytosis,GO:0008367~bacterial	  
binding	  
CG6509 2.9 
GO:0006955~immune	  
response,GO:0006959~humoral	  immune	  
response,GO:0019730~antimicrobial	  humoral	  
response	  
kis 3.1 
GO:0006955~immune	  
response,GO:0006959~humoral	  immune	  
response,GO:0019730~antimicrobial	  humoral	  
response	  
Rel 2.9 
GO:0006955~immune	  
response,GO:0006959~humoral	  immune	  
response,GO:0002784~regulation	  of	  antimicrobial	  
peptide	  production,GO:0002786~regulation	  of	  
antibacterial	  peptide	  
production,GO:0002788~regulation	  of	  antifungal	  
peptide	  production	  
zfh1 4.3 
GO:0002520~immune	  system	  
developmen,GO:0006955~immune	  
response,GO:0006959~humoral	  immune	  
response,GO:0019730~antimicrobial	  humoral	  
response	  
lola 3.5 
GO:0006955~immune	  
response,GO:0006959~humoral	  immune	  
response,GO:0019730~antimicrobial	  humoral	  
response	  
Toll-­‐2	   3.0 
GO:0006952~defense	  
response,GO:0006955~immune	  
response,GO:0006959~humoral	  immune	  
response,GO:0009617~response	  to	  
bacterium,GO:0019730~antimicrobial	  humoral	  
response,GO:0019731~antibacterial	  humoral	  
response,GO:0045087~innate	  immune	  response	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Ect4 3.5 
GO:0006952~defense	  
response,GO:0006955~immune	  
response,GO:0045087~innate	  immune	  response	  
Toll-­‐8	   3.4 GO:0006952~defense	  response,GO:0006955~immune	  response	  
mask 4.5 
GO:0006955~immune	  
response,GO:0006959~humoral	  immune	  
response	  
dom 3.2 
GO:0002520~immune	  system	  
developmen,GO:0030097~hemopoiesis,	  
GO:0035206~regulation	  of	  hemocyte	  
proliferation,GO:0035207~negative	  regulation	  of	  
hemocyte	  proliferation	  
E(bx) 3.3 
GO:0002520~immune	  system	  
development,GO:0030097~hemopoiesis	  
Su(H) 2.8 GO:0002520~immune	  system	  development	  
brm 3.1 
GO:0002520~immune	  system	  
development,GO:0006909~phagocytosis	  
ush 3.6 GO:0002520~immune	  system	  development	  
ken 3.6 
GO:0046425~regulation	  of	  JAK-­‐STAT	  
cascade,GO:0006909~phagocytosis	  
Socs16D 3.4 
dme04630:Jak-­‐STAT	  signaling	  
pathway,GO:0007242~intracellular	  signaling	  
cascade	  
Su(var)2-10 3.4 
GO:0046425~regulation	  of	  JAK-­‐STAT	  cascade,	  
dme04630:Jak-­‐STAT	  signaling	  pathway	  
Sos 3.0 dme04630:Jak-­‐STAT	  signaling	  pathway	  
Stam 3.1 
GO:0007259~JAK-­‐STAT	  
cascade,GO:0046425~regulation	  of	  JAK-­‐STAT	  
cascade,	  dme04630:Jak-­‐STAT	  signaling	  pathway	  
Cbl 6.3 dme04630:Jak-­‐STAT	  signaling	  pathway	  
csw 3.6 dme04630:Jak-­‐STAT	  signaling	  pathway	  
hop 3.1 
GO:0007259~JAK-­‐STAT	  
cascade,GO:0002252~immune	  effector	  
process,GO:0002520~immune	  system	  
development,GO:0006952~defense	  
response,GO:0006955~immune	  
response,GO:0006959~humoral	  immune	  
response,GO:0006968~cellular	  defense	  
response,GO:0007260~tyrosine	  phosphorylation	  
of	  STAT	  protein,GO:0007262~STAT	  protein	  
nuclear	  translocation	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Ars2 2.8 
GO:0016246~RNA	  
interference,GO:0050792~regulation	  of	  viral	  
reproduction,GO:0030422~RNA	  interference,	  
production	  of	  siRNA,GO:0031047~gene	  silencing	  
by	  RNA,GO:0031050~dsRNA	  
fragmentation,GO:0043331~response	  to	  
dsRNA,GO:0045069~regulation	  of	  viral	  genome	  
replication,GO:0045071~negative	  regulation	  of	  
viral	  genome	  replication,GO:0048525~negative	  
regulation	  of	  viral	  reproduction	  
Cbp80 3.8 
GO:0016246~RNA	  interference,	  
GO:0048525~negative	  regulation	  of	  viral	  
reproduction,GO:0030422~RNA	  interference,	  
production	  of	  siRNA,GO:0031047~gene	  silencing	  
by	  RNA,GO:0031050~dsRNA	  fragmentation	  
Dcr-2 3.1 
GO:0016246~RNA	  
interference,GO:0051607~defense	  response	  to	  
virus,	  GO:0002252~immune	  effector	  
process,GO:0030422~RNA	  interference,	  
production	  of	  siRNA,GO:0030423~RNA	  
interference,	  targeting	  of	  mRNA	  for	  
destruction,GO:0031047~gene	  silencing	  by	  
RNA,GO:0031050~dsRNA	  
fragmentation,GO:0033227~dsRNA	  
transport,GO:0035087~RNA	  interference,	  siRNA	  
loading	  onto	  RISC	  
AGO1 4.1 
GO:0016246~RNA	  interference,GO:0030422~RNA	  
interference,	  production	  of	  
siRNA,GO:0030423~RNA	  interference,	  targeting	  
of	  mRNA	  for	  destruction,GO:0031047~gene	  
silencing	  by	  RNA,GO:0031050~dsRNA	  
fragmentation	  
hdc 2.9 
GO:0016246~RNA	  
interference,GO:0031047~gene	  silencing	  by	  
RNA,GO:0035194~posttranscriptional	  gene	  
silencing	  by	  RNA	  
CG14995 3.0 GO:0048102~autophagic	  cell	  death	  
Doa 3.3 GO:0048102~autophagic	  cell	  death	  
emp 3.0 
GO:0006952~defense	  response,	  
GO:0048102~autophagic	  cell	  death	  
l(1)G0148 4.2 GO:0048102~autophagic	  cell	  death	  
Mmp1 2.9 GO:0048102~autophagic	  cell	  death	  
	  85	  
NAT1 2.9 GO:0048102~autophagic	  cell	  death	  
cbt 2.8 GO:0048102~autophagic	  cell	  death	  
br 3.7 GO:0006914~autophagy	  
Pi3K92E 3.5 GO:0048102~autophagic	  cell	  death	  
CycT 4.5 GO:0045449~regulation	  of	  transcription	  
fs(1)h 3.4 GO:0006355~regulation	  of	  transcription	  
NELF-A 3.3 GO:0006355~regulation	  of	  transcription	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Table S2. GO terms for P-TEFb-dependent, paused genes, related to Figure 6. The 
GO enrichment terms for the virally induced genes at 4 hours post-infection in 
Drosophila cells that are controlled by transcriptionally pausing, as defined by genetic 
Cdk9-dependence and pausing-associated chromatin features. All virally induced genes 
belonging to each GO category are provided. 
Category	   P-­‐value	   Number	  of	  Genes	   Gene	  Probe	  IDs	  
Immune	  
response	   2.05E-­‐02	   7	  
1628262_A_AT,	  1636513_A_AT,	  
1632067_AT,	  1637481_AT,	  
1627376_AT,	  1626509_AT,	  
1641226_A_AT	  
Autophagic	  cell	  
death	   1.08E-­‐02	   5	  
1639411_AT,	  1625761_A_AT,	  
1623605_A_AT,	  1625196_A_AT,	  
1640892_A_AT	  
MAPKKK	  
cascade	   2.27E-­‐03	   5	  
1632618_A_AT,	  1627394_S_AT,	  
1623605_A_AT,	  1631765_AT,	  
1637322_AT	  
Enzyme	  linked	  
receptor	  
protein	  
signaling	  
pathway	  
2.42E-­‐03	   8	  
1625775_A_AT,	  1632784_AT,	  
1632698_AT,	  1641518_A_AT,	  
1638189_S_AT,	  1625445_S_AT,	  
1635580_AT,	  1641226_A_AT	  
Ras	  protein	  
signal	  
transduction	  
4.69E-­‐03	   4	   1632618_A_AT,	  1635047_S_AT,	  1632784_AT,	  1624122_A_AT	  
Regulation	  of	  
RNA	  metabolic	  
process	  
7.88E-­‐04	   20	  
1628262_A_AT,	  1627796_S_AT,	  
1632602_S_AT,	  1627394_S_AT,	  
1636673_S_AT,	  1636034_AT,	  
1631371_S_AT,	  1637792_AT,	  
1625385_AT,	  1625445_S_AT,	  
1632418_S_AT,	  1633821_AT,	  
1624533_S_AT,	  1623441_AT,	  
1630023_AT,	  1627376_AT,	  
1628901_AT,	  1628385_A_AT,	  
1640892_A_AT,	  1623084_AT	  
Ion	  homeostasis	   2.55E-­‐02	   4	   1626807_A_AT,	  1626099_S_AT,	  1633112_AT,	  1636576_S_AT	  
Response	  to	  
organic	  
substance	  
1.94E-­‐02	   6	  
1632602_S_AT,	  1623441_AT,	  
1631481_A_AT,	  1638189_S_AT,	  
1633112_AT,	  1631055_AT	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Cell	  
proliferation	   5.48E-­‐03	   7	  
1624021_A_AT,	  1636034_AT,	  
1625116_AT,	  1634104_A_AT,	  
1628548_AT,	  1625445_S_AT,	  
1641226_A_AT	  
Cytoskeleton	  
organization	   2.15E-­‐03	   15	  
1624021_A_AT,	  1635047_S_AT,	  
1626143_A_AT,	  1639806_AT,	  
1638763_AT,	  1634009_AT,	  
1631055_AT,	  1641226_A_AT,	  
1627191_A_AT,	  1631765_AT,	  
1634509_S_AT,	  1634562_S_AT,	  
1635630_A_AT,	  1633112_AT,	  
1637897_AT	  
Syncytium	  
formation	   2.94E-­‐03	   4	  
1631013_AT,	  1634562_S_AT,	  
1628385_A_AT,	  1626591_AT	  
Cell	  projection	   4.18E-­‐04	   8	  
1624021_A_AT,	  1625761_A_AT,	  
1631013_AT,	  1639806_AT,	  
1637619_S_AT,	  1628548_AT,	  
1627191_A_AT,	  1636576_S_AT	  
Wnt	  signaling	  
pathway	   8.64E-­‐04	   6	  
1624300_S_AT,	  1634211_AT,	  
1628548_AT,	  1631055_AT,	  
1636576_S_AT,	  1623084_AT	  
Striated	  muscle	  
cell	  
differentiation	  
1.36E-­‐03	   6	  
1627394_S_AT,	  1631013_AT,	  
1634562_S_AT,	  1628385_A_AT,	  
1626591_AT,	  1623084_AT	  
Dorsal/ventral	  
pattern	  
formation	  
2.86E-­‐02	   6	  
1628759_A_AT,	  1625775_A_AT,	  
1623605_A_AT,	  1641170_A_AT,	  
1625445_S_AT,	  1635580_AT	  
Behavior	   1.00E-­‐03	   15	  
1636673_S_AT,	  1624300_S_AT,	  
1638189_S_AT,	  1623699_A_AT,	  
1625445_S_AT,	  1631055_AT,	  
1627248_AT,	  1636576_S_AT,	  
1632418_S_AT,	  1623503_AT,	  
1631498_A_AT,	  1628859_AT,	  
1640892_A_AT,	  1633112_AT,	  
1623084_AT	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CHAPTER 4 ERK signaling couples nutrient status to antiviral defense in the insect gut4 
 
1. Abstract 
 
A unique facet of arthropod-borne virus (arbovirus) infection is that they are 
orally-acquired by an insect vector during the taking of a blood meal, which directly links 
nutrient acquisition and pathogen challenge. While little is known about the antiviral 
molecular determinants of this “midgut barrier,” we show that the nutrient responsive 
ERK pathway is both induced by and restricts disparate arboviruses in Drosophila 
intestines. Wild type flies are refractory to oral infection by arboviruses, but this innate 
restriction can be overcome chemically by oral administration of an ERK pathway 
inhibitor or genetically via the specific loss of ERK in the intestinal epithelial cells. 
Vertebrate insulin, which activates ERK in the mosquito gut during a blood meal, 
restricts viral infection in insect cells and this protects against viral invasion of the insect 
gut epithelium. These studies suggest that insects take advantage of cross-species 
signals in the meal to activate antiviral immunity.  
 
2. Background 
 
Many (re)emerging pathogens are arthropod-borne, transmitted via an insect 
vector, and cause significant global health and agricultural problems [4].  Initial host 
encounters with microbial pathogens occur locally, usually at an epithelial surface [36]. 
While systemic immune responses have been extensively studied in insects by 
introducing a variety of pathogens into the body cavity [29,56], much less is known about 
local responses at epithelial surfaces [28,32,33,36], particularly against orally-acquired 
viral pathogens [62,87]. Oral acquisition of arboviruses during a blood meal must 
overcome gut barrier immunity for infection of the intestinal epithelium necessary to 
establish systemic infection [25,28,33,216]. Indeed, studies have demonstrated that a 
major barrier to transmission of arboviruses from a vertebrate host is at this step in the 
infection cycle, although there are few molecular determinants known to be active within 
the gut epithelial cells that protect against viral invasion [24,34,62,87]. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4 Portions of this chapter is from Xu J, Hopkins K, Sabin LR, Yasunaga A, Lamborn I, Gordesky-
Gold B, Yasunaga A, and Cherry S. Erk signaling couples nutrient status with antiviral defense in 
the insect gut. (Submitted). 
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Given that a unique facet of arthropod-borne virus (arbovirus) infection is that 
these pathogens are orally-acquired by an insect vector during the taking of a blood 
meal, [4,217] there is a direct link between nutrient acquisition and pathogen challenge. 
A coupling of this nutrient rich signal with host defense would likely benefit the organism. 
Here we show that the nutrient responsive ERK pathway is both induced by and restricts 
disparate viral infections, including human arboviruses, in Drosophila and mosquito cells. 
Furthermore, ERK signaling is essential for antiviral defense in the insect intestinal 
epithelium. While wild type flies are refractory to oral infection by arboviruses including 
Sindbis virus (SINV) and Vesicular Stomatitis virus (VSV), this innate restriction can be 
overcome chemically by oral administration of an ERK pathway inhibitor or genetically 
via the specific loss of ERK in the intestinal epithelial cells. Either treatment results in 
robust viral infection of the gut. Furthermore, vertebrate insulin that activates ERK 
signaling in the mosquito gut during a blood meal [150] can both restrict viral infection in 
insect cells and protect against viral invasion of the gut epithelium. These studies 
collectively demonstrate that ERK signaling in the insect intestines potently restricts viral 
infection suggesting that insects take advantage of signals in the meal to preemptively 
activate antiviral immunity.  
 
3. Results 
 
ERK Signaling is Activated by and Restricts Viral Infections in Drosophila Cells 
To elucidate such antiviral mechanisms in insects, we took advantage of the 
model organism Drosophila melanogaster, which is a powerful genetically tractable 
system for study [29]. Indeed, many antiviral pathways in insect vectors were first 
discovered using Drosophila [56]. Using cell-based RNA interference (RNAi) screening 
for novel antiviral factors in Drosophila cells, we previously discovered that NELF-
dependent transcriptional pausing controls early responses to infection by disparate 
medically relevant arboviruses [132]. This transcriptional response includes genes from 
all known Drosophila antiviral pathways suggesting that additional genes from within this 
gene set may have antiviral activity. MAPK signaling components, not previously 
implicated in antiviral defense, were both transcriptionally induced and over-represented 
in this gene set (Figure S1). Given that there are three related and conserved MAPK 
signaling pathways (ERK, JNK and p38) [89], two of which have positive roles in 
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immunity spanning flies to humans (JNK and p38) [112,115,218,219], we performed a 
directed RNAi screen of 24 core components of these pathways to determine their cell-
intrinsic activity against Vesicular Stomatitis virus (VSV), Sindbis virus (SINV), and 
Drosophila C virus (DCV) [122,144]. VSV and SINV are arboviruses belonging to two 
disparate families (Rhabodoviridae and Alphaviridae, respectively) whose natural cycle 
involves transmission between insects and vertebrates. DCV is a natural Drosophila 
pathogen that does not infect vertebrates [220].  
We found that 6 canonical ERK signaling components (dSos, dRas (Ras85D), 
dMek (Dsor1), dErk (rl), ksr, and cnk) restrict VSV, SINV, and DCV infection of 
Drosophila cells, as their depletion causes a significant increase in the percentage of 
infected cells as compared to controls (Figure 1A-C, Figure S1 and Table S1). We also 
found increased viral protein and RNA levels in cells depleted of ERK pathway 
components, as measured by immunoblot and quantitative RT-PCR respectively (Figure 
S2-S3). In contrast, depletion of core components of the other two MAPK pathways 
(JNK, p38) did not alter the percentage of VSV, SINV or DCV infected cells (Figure 1B-C 
and Table S1). 
Using an orthogonal approach, we took advantage of the ERK pathway inhibitor 
U0126 that blocks MEK activation in diverse species, [221,222] including Drosophila 
[223] [224]. Using an antibody that recognizes activated Drosophila Erk, we found that 
vertebrate insulin (3.5 µM) induces Erk activation within 15 minutes (Figure S4A). 
Treatment with U0126 inhibits both basal and insulin-induced Erk activation in a dose-
dependent manner, [223] while having no impact on cell number (Figure S4A-B). 
Further, Drosophila cells treated with U0126 (10 µM) were more permissive to infection 
as there were higher levels of infections of VSV, SINV and DCV compared to controls 
(Figure 1D and S4C), which was dose-dependent (Figure S5).  
Next, we tested whether ERK signaling is activated by viral infection in 
Drosophila cells. We found VSV, SINV and DCV activated Erk within 60 minutes as 
measured by increased phospho-Erk levels (Figure 1E-G), a time point prior to viral 
replication [132]. This signal was specific, as total Erk levels are unaffected by viral 
infection, and Erk depletion by RNAi leads to a loss of both phospho-Erk and total-Erk 
(Figure 1E-G). These findings suggest that viral infection is sensed by Drosophila cells 
leading to the rapid induction of an antiviral ERK signaling cascade. 
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The Antiviral Activity of the Erk Pathway is Conserved in Mosquito Cells 
Since insect vectors, including Aedes aegypti mosquitoes, can transmit 
arboviruses such as SINV [35], we set out to determine if the ERK pathway is antiviral in 
mosquito cells. We depleted Aedes aegypti Aag2 cells of Sos (AAEL001165) or Mek 
(AAEL012723) by RNAi and compared the percentage of infected cells to non-targeting 
controls using microscopy. We found that Sos and Mek are antiviral against VSV and 
SINV in mosquito cells (Figure 2A-B). Moreover, we observed higher viral protein 
expression and viral RNA levels upon VSV and SINV infection in Sos- and Mek-depleted 
Aag2 cells, as measured by immunoblot and quantitative RT-PCR respectively (Figure 
2C-D). We could not infect mosquito cells with DCV (data not shown), which is 
consistent with the fact that DCV is a natural pathogen of Drosophila with a very narrow 
host range [220].  As we observed in Drosophila, vertebrate insulin (3.5 µM) induces Erk 
activation within 15 minutes in Aag2 cells (Figure 2E) and treatment with the ERK 
pathway inhibitor U0126 (10 µM) also prevents both basal and insulin-induced phospho-
Erk, similar to published findings in other mosquito species (Figure 2E) [222]. We also 
found that cell number was not affected by either insulin or U0126 drug treatment of 
Aag2 cells (Figure S6). Treatment of mosquito cells with U0126 led to increases in VSV 
and SINV infection compared to control cells (Figure 2F-G). Furthermore, we found that 
viral infection also rapidly activates the ERK pathway in mosquito cells as measured by 
phospho-Erk (Figure 2H). Altogether, our findings suggest that ERK signaling plays a 
conserved antiviral role in diverse insects. 
 
The Erk Pathway Protects the Insect Gut From Infection upon Ingestion of Virus 
Arboviruses are naturally transmitted to insect vectors during the ingestion of a 
nutrient rich blood meal [4]. Since ERK signaling can be activated in the mosquito 
digestive tract by nutrients and insulin in the blood meal [150,222], we reasoned that the 
ERK pathway may couple signals in the meal with antiviral defense to protect insects 
from orally-acquired viral infections, including arboviruses. To determine whether ERK 
activity in the gut impacts local viral susceptibility, we took advantage of U0126 to inhibit 
ERK signaling in the gut epithelium. We fed wild type flies with either vehicle or U0126 
(0.5 mM) and found that drug treatment attenuated intestinal phospho-Erk levels while 
having no impact on total Erk levels (Figure 3A). Moreover, we found that oral 
administration of adult flies with U0126 (0.5 mM) did not alter feeding as measured by 
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the ingestion of dye or survival compared to vehicle fed flies (Figure S7A-B). Next, we 
fed flies with vehicle or U0216 (0.5mM) along with the arboviruses VSV or SINV. At 7 
days post-infection, we found that vehicle-fed flies had undetectable levels of viral 
infection in their midguts as measured by microscopy that monitors viral antigen 
expression in infected intestinal cells (Figure 3B) or quantitative RT-PCR that monitors 
viral RNA levels in whole intestines (Figure 3C-D). In contrast, flies fed with the ERK 
pathway inhibitor had increased viral infection of midgut cells as measured by 
microscopy (Figure 3B). Furthermore, we observed increased viral RNA in ERK pathway 
inhibited intestines as measured by quantitative RT-PCR (Figure 3C-D).  
While VSV and SINV do not naturally infect Drosophila, DCV is a natural 
pathogen of Drosophila melanogaster that can be orally transmitted [225]. In contrast to 
the infections with VSV and SINV, vehicle-fed flies orally challenged with DCV had 
detectable infection of the midgut by 7 days post-infection, as measured by 
immunofluorescence (Figure 3B), and viral RNA by quantitative RT-PCR (Figure 3E). 
Furthermore, we observed increased phospho-Erk in the gut at two hours post-DCV 
ingestion compared to controls (Figure 3A). As we observed with VSV and SINV, ERK 
inhibition led to significantly increased DCV infection, as measured both by 
immunofluorescence and quantitative RT-PCR (Figure 3B, 3E). Hence, ERK signaling is 
both activated by and restricts viral infection in the gut epithelium. 
 
Erk Acivation Occurs Within Gut Enterocytes to Confer Antiviral Immunity 
The Drosophila midgut is a simple epithelium where multipotent stem cells give 
rise to enteroblasts that subsequently differentiate into either enterocytes characterized 
by large nuclei, or secretory enteroendorcine cells [148]. Midgut enterocytes are 
responsible for nutrient uptake, and are also the first cell type infected by arboviruses in 
vector mosquitoes [28,33,87]. We observed that the midgut enterocytes were infected by 
all three viruses in U0126 fed flies (Figure S8A-C). Therefore, we hypothesized that the 
Erk-dependent antiviral function is active within enterocytes.  To test this, we took 
advantage of the MyoIA-Gal4 driver that selectively expresses Gal4 in midgut 
enterocytes [226,227]. We used this system to drive expression of an inverted repeat 
transgene to perform in vivo RNAi against Erk and found that total Erk levels in 
MyoIA>Erk IR guts were reduced compared to controls (Figure 3F). Flies with 
enterocyte-specific Erk depletion had no change in feeding behavior, or survival 
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compared to controls (Figure S9A-B). Next, we fed MyoIA>Erk IR flies with VSV, SINV, 
or DCV and observed significantly increased infection in midgut enterocytes compared 
to controls, as measured both by microscopy and quantitative RT-PCR (Figure 3G-J). 
These studies demonstrate that ERK signaling in enterocytes restricts orally-acquired 
viral infections within the insect digestive tract. 
 
Insulin-Induced Erk Activation in the Gut Protects Against Viral Infection 
Previous studies have shown that growth factors found within the blood meal, 
including vertebrate insulin, can activate the ERK pathway in the mosquito intestines 
[222]. Hence, we hypothesized that the ERK pathway may couple nutrient acquisition 
and signals within the meal to trigger antiviral defense in gut enterocytes. To test this, we 
first determined whether insulin-induced ERK pathway activation in cell culture protects 
against viral infection (Figure 2E, S5). Indeed, we found that insulin (3.5 µM) protects 
Drosophila cells from SINV and DCV infection (Figure 4A), while having no impact on 
cell number (Figure S6B and S10). Likewise, mosquito cells are protected from SINV 
infection by insulin (3.5 µM) treatment (Figure 4B). Next, we tested whether feeding 
insulin to flies can trigger ERK signaling in the gut. Perhaps surprisingly, we observed 
robust Erk activation within 30 minutes post-insulin feeding (85 µM) as measured by 
phospho-Erk (Figure 4C), similar to previous reports in the vector mosquito Anopheles 
stephensi [150]. Furthermore, we found that oral administration of insulin (85 µM) did not 
alter feeding behavior or survival compared to vehicle fed flies (Figure S11A-B). Next, 
we tested whether insulin-induced ERK activation altered viral infection of midgut 
enterocytes. To this end, we fed flies with either vehicle or insulin (85 µM) along with 
DCV. We found that insulin-fed flies had decreased infection of their intestines compared 
to controls, both by immunofluorescence and quantitative RT-PCR (Figure 4D-E). We 
were unable to test insulin-dependent attenuation of VSV or SINV infection of the gut, as 
we could not detect infection by these viruses in untreated wild type intestines (Figure 
3B-D). 
 
4. Discussion 
 
 The intestinal epithelium has been long recognized as a major determinant of 
vector competence. This “midgut barrier” acts as a blockade to prevent pathogenic 
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invasion and systemic dissemination of arboviruses in insects [36,216]. Studies have 
found genetic associations with virus restriction within this barrier, but few molecular 
antiviral determinants have been identified [33,36,62,87,228,229]. Enterocytes secrete 
antimicrobial peptides and reactive oxygen species upon pathogenic bacterial infection, 
and instestinal stem cell self-renewal also confers protection upon epithelial damage 
from such infections [226,230,231], but the spectrum of intestinal epithelial cell-intrinsic 
antiviral responses are largely unexplored [36]. We identified the ERK pathway as a cell-
intrinsic regulator of intestinal immunity. Since ERK is a negative regulator of 
antibacterial gene expression through the IMD pathway in Drosophila, although not in 
enterocytes per se [69], we tested the role of the IMD pathway in intestinal antiviral 
immunity and found that the there is no basal induction of IMD signaling upon Erk 
depletion in enterocytes nor downstream of viral infection in the gut as measured by 
DiptB expression (Figure S12 and S13). Further studies will define the downstream 
mechanism by which ERK exerts its antiviral effects. 
We postulate that since arboviral challenge of the insect gut, as well as other 
enteric viruses, occurs during feeding, the use of the nutrient responsive ERK signaling 
pathway in the epithelium allows the organism to couple nutrient signals with immune 
defense. Given the energetic costs in mounting an immune response [232] and the 
potentially toxic production of immune effectors [233], the coupling of signals in the meal 
with antiviral defenses restricts the response to times when the organism is most 
vulnerable. Furthermore, it has become increasingly clear that there are important 
interactions between diet and immune function[234], which the ERK pathway may play a 
role. Lastly, since this pathway can be manipulated by altering nutrient status, 
pharmacologically or genetically, this suggests novel control strategies for arboviral and 
other orally-acquired viral infections in insects. 
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Figure 1. The ERK pathway is broadly activated by and restricts viral infections in 
Drosophila cells. (A) ERK pathway schematic. (B) Drosophila cells treated with the 
indicated dsRNAs challenged with VSV (MOI=0.2), SINV (MOI=5), or DCV (MOI=1.5) 
and monitored by fluorescence microscopy (virus in green, nuclei in blue). (C) 
Quantification of images in (A) with mean ± S.D. of three independent experiments; *p < 
0.05. (D) Drosophila cells treated with PBS or U0126 (10 µM) challenged with VSV, 
SINV or DCV as in (A). Quantification of images with mean ± S.D. of three independent 
experiments; *p < 0.05. (E-F) Immunoblot analysis of Drosophila cells infected with VSV, 
SINV, or DCV, as indicated. (MAPK screening was performed by Jie Xu, Kaycie 
Hopkins, and Ian Lamborn; Phospho-westerns were performed by Ari Yasunaga). 
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Figure 2. The ERK pathway is antiviral in mosquito cells. (A) Aedes aegypti Aag2 
cells treated with the indicated dsRNAs were challenged with VSV (MOI=0.01) or SINV 
(MOI=0.5) and monitored by microscopy (virus, green; nuclei, blue). (B) Quantification of 
(A) with mean ± S.D. of three independent experiments; *p < 0.05. (C) Immunoblot 
analysis of Aag2 cells treated as in (A). (D) Quantitative RT-PCR analysis of viral RNA 
normalized to Rp49 and shown relative to control cells treated as in (A). Mean ± S.D. of 
three independent experiments; *p<0.05. (E) Immunoblot analysis of Aag2 cells treated 
with insulin (3.5 µM) or U0126 (10 µM) for 15 minutes. (F) Aag2 cells treated with PBS 
or U0126 (10 µM), infected with the indicated virus, and monitored by microscopy. (G) 
Quantification of images in (F) with mean ± S.D. of three independent experiments; *p < 
0.05. (H) Immunoblot analysis of Aag2 cells infected with SINV 60 minutes post-
infection. (Phospho-westerns were performed by Ari Yasunaga). 
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Figure 3. ERK signaling protects against viral infection of the insect gut. 
 (A) Immunoblot analysis of wild type flies fed PBS or U0126 (5 mM) for 1 hour. (B) 
Representative images of midguts from flies fed PBS or U0126 and orally challenged 
with the indicated virus for 7 days. (virus, green; nuclei, blue). (D-F) Quantitative RT-
PCR analysis of viral RNA normalized to Rp49 and shown as relative to the controls 
from midguts 7 days post-infection in flies treated as in (B). Mean ± S.D. of three 
independent experiments; *p<0.05. (G) Immunoblot analysis of MyoIA>+ and MyoIA>Erk 
IR midguts. (H) Representative images of midguts from MyoIA>+ or MyoIA>Erk IR flies 7 
days post infection. (virus, green; nuclei, blue). (I-K) Quantitative RT-PCR analysis of 
viral RNA normalized to Rp49 and shown relative to the control from midguts isolated at 
7 days post-infection as in (G). Mean ± S.D. of three independent experiments; *p<0.05. 
(Fly husbandry was performed by Beth Gordesky-Gold, phospho-westerns were 
performed by Ari Yasunaga). 
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Figure 4. Insulin protects against viral infection of the gut. (A) Drosophila cells were 
either mock or insulin-treated, infected with SINV or DCV, and monitored by microscopy 
(virus, green; nuclei, blue). (B) Quantification of images in (A) with mean ± S.D. of three 
independent experiments; *p < 0.05. (C) Mosquito Aag2 cells were either mock or 
insulin-treated, infected with SINV and monitored by microscopy (virus, green; nuclei, 
blue). (D) Quantification of images in (C) with mean ± S.D. of three independent 
experiments; *p < 0.05. (E) Immunoblot analysis of intestines from wild type flies fed 
PBS or insulin for 30 minutes. (F-G) Flies were fed either PBS or insulin and orally 
challenged with DCV for 7 days. DCV infection of intestines analyzed by (F) microscopy 
(virus, green; nuclei, blue) or (G) quantitative RT-PCR normalized to Rp49 and shown 
relative to the control. Mean ± S.D. of five independent experiments; *p<0.05. (Phospho-
westerns were performed by Ari Yasunaga). 
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CHAPTER 4 – SUPPLEMENTAL FIGURES AND TABLES 
 
 
Table S1. RNAi screening results for the three MAPK pathways (ERK, JNK, and p38) in 
Drosophila cells against VSV, SINV, and DCV.  (MAPK screening was performed by Jie 
Xu, Kaycie Hopkins, and Ian Lamborn). 
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Figure S1. Summary schematic for the results of the directed RNAi screen for 
ERK, JNK, and p38 pathways. Genes highlighted in gray represent the Drosophila 
MAPKKK, MAPKK, and MAPK homologues for each pathway, respectively. Genes 
boxed in red are antiviral for VSV, SINV, and DCV. Genes boxed in black are not 
antiviral for all three viruses. Genes boxed in blue are transcriptionally induced by VSV 
infection. (MAPK screening was performed by Jie Xu, Kaycie Hopkins, and Ian 
Lamborn). 
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Figure S2. Depletion of ERK pathway components results in increased viral 
protein expression in Drosophila cells. (A-F) Immunoblot analysis of Drosophila cells 
treated with dsRNA targeting the indicated ERK pathway components and infected with 
(A,B) VSV-GFP, (C,D) SINV-GFP, or (E,F) DCV.  
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Figure S3. Depletion of ERK pathway components results in increased viral RNA 
levels in Drosophila cells. Quantitative RT-PCR analysis of Drosophila cells treated 
with the indicated dsRNA and infected with the indicated virus. Viral RNA levels are 
normalized to Rp49 and shown as a relative fold change compared to the control. Mean 
± S.D. of three independent experiments is shown; *p<0.05. 
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Figure S4. U0126 treatment prevents Erk activation and is antiviral. (A) Immunoblot 
analysis of Drosophila cells treated with insulin (3.5 µM) and/or U0126 (10 µM) for 15 
minutes. (B) Cell number quantification for three independent experiments using 
automated image analysis of PBS or U0126-treated Drosophila cells  (ns,  not 
significant). (C)  Representative immunoflorescent images of  Drosophila cells treated 
with PBS or U0126 (10 µM) and challenged with VSV, SINV, or DCV (virus, green; 
nuclei, blue). (Phospho-western was performed by Ari Yasunaga). 
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Figure S5. U0126 treatment results in increased viral infection in Drosophila cells 
in a dose-dependent manner. (A) Immunoblot analysis of Drosophila cells treated with 
and the indicated concentration of U0126 in the presense or absence of insulin. (B) 
Quantification in the change in percentage of SINV infection over a range of U0126 
inhibitor treatment, performed in duplicate. (Phospho-western was performed by Ari 
Yasunaga). 
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Figure S6. Insulin or U0126 drug treatment of Aag2 cells does not alter cell 
number. Quantification of cell number in Aag cells treated with PBS versus (A) U0126 
(10 µM) or (B) Insulin (3.5 µM) for three independent experiments (ns, not significant).  
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Figure S7. Oral treatment with U0126 does not alter feeding behavior or viability of 
flies. (A) Representative images of flies fed with PBS or U0126 (5 mM) along with red 
dye for 7 days. (B) A representative survival curve for 50 flies as in (A). 
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Figure S8. Fluorescence images of VSV, SINV, and DCV infection in the insect gut. 
Female flies treated with U0126 and challenged with VSV, SINV, or DCV and monitored 
by fluorescence microscopy (virus, green; nuclei. blue). Enterocytes are characterized 
by large nuclei (arrow head) while stem cells are small (arrow). The majority of infected 
cells have large nuclei. 
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Figure S9. Flies with Erk-depleted intestines do not have differences in feeding 
behavior or viability. (A) Representative images of MyoIA>+ and MyoIA>Erk IR fed 
with red dye for 7 days. (B) A representative survival curve for 20 flies as in (A). 
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Figure S10. Insulin treatment of Drosophila cells does not alter cell number. 
Quantification of cell number in Drosophila cells treated with PBS versus insulin (3.5 µM) 
for three independent experiments (ns, not significant).  
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Figure S11. Oral treatment with insulin does not alter feeding behavior or viability 
of flies. (A) Representative images of flies fed with PBS control or insulin (85 µM) along 
with red dye for 7 days. (B) A representative survival curve for 50 flies as in (A). 
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Figure S12. Erk depletion in enterocytes do not alter Diptericin B expression in the 
Drosophila gut. Quantitative RT-PCR analysis of MyoIA>+ and MyoIA>Erk IR midguts 
for Diptericine B (DiptB) expression, normalized to Rp49 and shown relative to MyoIA>+. 
Mean ± S.D. of three independent experiments (ns, not significant). (Fly husbandry was 
performed by Beth Gordesky-Gold). 
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Figure S13. Viral infection does not induce Diptericin B expression in the 
Drosophila gut.  (A-C) Quantitative RT-PCR analysis of Diptericin B (DiptB) for 
MyoIA>+ flies challenged with the indicated virus, normalized to Rp49, and shown 
relative to MyoIA>+ uninfected flies. Mean ± S.D. of three independent experiments (ns, 
not significant). (Fly husbandry was performed by Beth Gordesky-Gold). 
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CHAPTER 5. Concluding Remarks 
Many (re) emerging pathogens are arthropod-borne, transmitted via an insect 
vector, and cause significant global health and agricultural problems [1,4,5]. Using the 
model organism Drosophila melanogaster, this thesis explores novel cell-intrinsic innate 
immune pathways that target arboviral infections, thereby contributing to both our 
knowledge of cell biology and virus-host interactions for pathogens that cause emerging 
infectious diseases. 
1. Transcriptional Pausing as a Novel Antiviral Restriction Mechanism in Insects 
In Chapter III, using a cell-based RNAi screening approach against a panel of 
disparate arboviral pathogens, we initially identified two broadly antiviral candidates 
belonging to the NELF complex, NELF-B and NELF-D. This chapter subsequently 
explores and characterizes this NELF-mediated antiviral activity, identifying a novel 
antiviral transcriptional regulatory mechanism called transcriptional pausing. The current 
paradigm for orchestrating innate immune responses is at the step of transcription 
initiation and how other transcriptional regulatory mechanisms play a role in 
orchestrating immune responses are less clear, particularly across a diverse range of 
pathogens and hosts. We found that core components of the transcriptional pausing 
pathway, including NELF, P-TEFb and DSIF complexes, are broadly antiviral in a variety 
of Drosophila cell lines (Figure 1). Subsequently, we found that this pathway is antiviral 
in vector mosquito cells and in adult flies (Figure 7). Given that antiviral transcriptional 
programs are not well characterized in insects, which lack the Interferon response, we 
performed gene-expression profiling to characterize the rapidly activated and virally 
induced response in Drosophila cells. This revealed that a transcriptional program is 
induced within one hour of arboviral infection, including genes within the known antiviral 
pathways such as JAK/STAT signaling (Figure 3, Table S1). Surprisingly, over half of 
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this early transcriptional program depends on transcriptional pausing and exhibit 
pausing-associated chromatin features. These findings are striking, since only ~2% of 
the basal Drosophila transcriptome depend on pausing factors for their expression. In 
summary, by taking advantage of both genetic and biochemical approaches, we 
illustrate that transcriptional pausing plays a major role in the control of insect antiviral 
immunity through antiviral gene regulation. 
Our newly described antiviral transcriptional program parallels many aspects of 
the LPS-induced macrophage response [58,59,176], as both translation-independent 
and translation-dependent targets were identified (Figure 4). It is interesting to note that 
some LPS-induced primary response genes, like the transcription factor IkappaBzeta, 
control downstream secondary responses in mammalian systems [213]. Whether any of 
our virally induced primary response genes drive subsequent gene expression is an 
open question. We did find that thirty-two genes are both pausing-regulated and involved 
in transcription as defined by annotated GO terms, including transcription factors and 
chromatin modifiers. Studying how these virally-induced and pausing-regulated factors 
can potentially modify the transcriptional landscape to instruct secondary response 
genes will further inform us of how early rapid signals become integrated.  
Of the virally induced genes, we identified nine transcription factors that are 
conserved with humans, including NFκB (Relish) that already has well established roles 
in antiviral defense [83]. In addition, there are five genes related to chromatin-
modification, which may also help regulate subsets of secondary loci. Two of these 
genes, kismet and trithorax, have been implicated to counteract polycomb repression 
and turn on gene expression during Drosophila development [235,236]. Our preliminary 
RNAi screening of these chromatin modifiers and transcription factors have revealed that 
3 of these factors restrict viral infection, while 9 others remain untested. We hypothesize 
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that these factors may regulate a subset of the subsequent antiviral transcriptional 
response. Performing additional transcriptional profiling in the context of RNA silencing 
of these factors may help identify their roles in driving antiviral secondary responses.  
The rapidly induced antiviral program does not include genes from known 
antiviral signaling pathways, particularly JAK/STAT, Toll, and IMD pathways. This 
suggests that these classic pathways are not responsible for inducing this gene 
expression program and alternate upstream viral sensor(s) are likely triggering the 
pausing-regulated response during early infection. We have found that UV-inactivated 
VSV and SINV can activate this gene expression program, suggesting that incoming 
virions are sensed by cells to induce this response rather than viral replication products. 
Future work will involve both the characterization of the upstream signals leading to P-
TEFb recruitment for gene activation as well as the viral PAMP(s) that trigger this 
response. 
Our genome-wide profiling experiments reveal that known antiviral pathways are 
transcriptionally induced during early infection, suggesting that additional genes within 
our gene-set may also have roles in antiviral immunity. Indeed, amongst the induced 
genes were components of all known antiviral pathways in Drosophila, including RNA 
silencing, autophagy, Toll signaling, IMD signaling, and JAK-Stat signaling, suggesting 
that this gene set is rich with important players in antiviral defense. In addition, we have 
also characterized the transcriptional response during early SINV infection, which 
strikingly overlaps with VSV by 49% (data not shown). This is consistent with the notion 
that an underlying level of coordination exists in the host induction of responses against 
disparate viruses. This is analogous to antiviral transcriptional programs in mammals, 
where virus recognition by pattern recognition receptors also induces a core set of 
genes, only a subset of which is active against any given virus [57,58,237]. A particular 
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group of virally induced genes that should be further explored is the Toll receptors. In 
addition to Toll itself, we found that three other pausing-regulated Toll receptors (Toll-2, 
Toll-7, and Toll-8) are transcriptionally induced by VSV and SINV infection (Figure 4). 
We recently found that Toll-7 is antiviral against VSV via the autophagy pathway [64]. 
Interestingly, 9 other autophagy-associated genes are also rapidly induced by VSV 
infection (Table S1D) [64,117]. Toll-2 may play a minor role in antibacterial immunity 
[208,209]. Toll-8 negatively regulates local immune responses to bacterial challenge 
[210,211]. Whether Toll-2, Toll-8, or additional Drosophila Toll receptors play roles in 
antiviral defense remains an open question. Furthermore, whether transcriptional 
pausing regulates mammalian TLR expression or other pattern recognition receptors 
downstream of viral infection is unknown. Hence, future exploration of these rapidly 
induced genes may reveal additional aspects of the innate immune arsenal. 
In conclusion, the transcriptional pausing pathway restricts disparate arboviruses 
in cell culture and at the organismal level. Whether other insect immune responses are 
controlled by similar mechanisms is largely unknown [214]. Furthermore, whether 
pausing similarly controls antiviral defense in mammals is also unknown. Nevertheless, 
our findings in conjunction with published literature suggest that transcriptional pausing 
is associated with rapid gene induction and may serve as a robust mechanism for the 
immediate defense against a variety of pathogens across diverse hosts [170,176,215]. 
Future work examining the role of transcriptional pausing in these various contexts may 
help define how paused genes are differentially activated and may also lead to the 
development of therapeutic strategies for infectious diseases. 
 
2. ERK signaling as a Novel Antiviral Restriction Mechanism in the Insect Gut 
In insect vectors, epithelial barriers act in concert with local and systemic immune 
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responses to confer protection against arboviral pathogens. The “midgut barrier” is 
particularly important as the initial point of infection for arboviral pathogens upon blood 
meal ingestion and also prevents systemic viral dissemination [25,26,36]. This organ 
also plays the principal role in sensing the nutritional status of the animal, as diet and 
commensal activity can alter insect physiology [238-240]. Despite the important 
contribution of the “midgut barrier” to vector competence, little is known about the 
particular antiviral mechanisms at play.  
In Chapter IV, a new component of the “midgut barrier” is discovered and 
characterized. The ERK pathway is classically implicated in nutrient signaling in insects, 
becoming activated upon blood meal ingestion in mosquitoes. Although its role in 
antiviral immunity had not been characterized in insects, ERK pathway components 
were amongst the virally induced genes from Chapter III. Subsequent directed RNAi 
screening of the ERK pathway revealed that it has broad antiviral activity in Drosophila 
and Aedes cells (Figure 1 and Table S1). In addition, ERK signaling is induced within 45 
minutes of infection by disparate viruses in these cell types (Figure 1 and 2). Given 
ERK’s role in nutrient acquisition, we examined its role at the organismal level. We found 
that ERK signaling plays a fundamental role in restricting viral infection in the intestines 
and ingestion of viral particles can activate ERK signaling in the gut (Figure 3). In 
particular, ERK signaling is important in the absorptive enterocytes that make up the gut 
epithelium (Figure 3). Surprisingly, we found that components within a blood meal itself 
can also trigger ERK activation and confer protection, as vertebrate insulin restricts 
infection of the gut (Figure 4). Altogether, our findings suggest that ERK signaling in the 
insect intestines potently restricts viral infection and insects may take advantage of 
signals in the meal to preemptively activate antiviral immunity. 
Given that ERK signaling in insect gut enterocytes mediate local immunity to viral 
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infection, future studies will include the identification of upstream signals that trigger this 
signaling cascade. How viral infection can trigger ERK activation in Drosophila 
intestines, Drosophila cells and mosquito cell lines is unknown. Our preliminary studies 
in Drosophila cell lines suggest that virally-mediated Erk activation is likely indirect, as 
virus-dependent ERK phosphorylation requires the synthesis of new factors 
(Cycloheximide-dependent, data not shown). Given that there are five major receptor-
tyrosine kinases (RTKs) that can be upstream of Drosophila Erk signaling (sevenless 
(Sev), torso (tor), Insulin Receptor (InR), Epidermal Growth Factor receptor (EGFR), and 
PDGF- and VEGF-receptor related (PVR) receptor) [105,241-243], we subsequently 
screened these receptors for antiviral activity using RNAi in Drosophila cells. We found 
that only PVR is broadly antiviral against VSV, SINV, and DCV in cells (data not shown). 
Screening of the three PVR ligands (pvf1-3) revealed that pvf2 is also pan-antiviral (data 
not shown) [69,243]. At the organismal level, pvf2 has been found to be secreted by 
visceral muscle surrounding the gut to help maintain gut stem cells [244], but its potential 
role in ERK activation in enterocytes is unknown. Hence, it would be important to 
determine whether virally induced ERK activation in gut enterocytes is dependent on 
PVR or any of the other RTKs to confer antiviral immunity in the gut upon viral challenge. 
We also found that ingestion of vertebrate insulin can trigger ERK activation in 
the insect intestines and provides protective immunity. Therefore, it will be equally 
important to dissect the mechanisms by which the antiviral ERK pathway is triggered in 
this context. Our findings with vertebrate insulin suggest that InR is located on insect 
enterocytes facing the lumen, but it is unclear why insects would evolve to detect insulin 
in this anatomical location. Furthermore, it is known that insects produce insulin-like 
peptides in the brain to hormonally regulate various tissues upon ingestion of a large 
bolus of nutrients [245-247]. Given our findings that vertebrate insulin is protective 
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against infection in both Aedes and Drosophila cells, it would be interesting to determine 
whether insulin-like peptides can also confer protection in cells via InR and at the 
organismal level through the ERK pathway. Interestingly, it is known that ERK signaling 
helps promote systemic InR expression in insects [223], which may act as a feed 
forward loop given that insulin signaling via InR promotes ERK activation itself. 
Characterizing the potential antiviral role of foreign and endogenous insulin would be 
very interesting, as they both play a role during food ingestion for hematophagous 
insects. Hypothetically, ERK activation via insulin signaling may be a way for vector 
insects to systemically signal to cells both for nutrient acquisition as well as antiviral 
defense. 
It is currently unknown which RTK(s) are active on enterocytes and what 
downstream genes are induced by ERK activation in these absorptive cells [148]. The 
identification of downstream ERK-dependent antiviral pathways can shed light into how 
Erk signaling helps control gut antiviral immunity and determine viral permissivity. We 
hypothesized that ERK directs antiviral gene expression through one of its four known 
ERK-regulated transcription factors, and directed RNAi screening in cells revealed that 
pointed (pnt) is the pan-antiviral transcription factor (data not shown). This led us to 
perform expression profiling of Drosophila cells to identify the virally induced genes that 
are mediated by ERK signaling during early infection. Comparison of the VSV-induced 
transcriptional program to the dMek-depleted program revealed that 12% (65 genes) of 
the early antiviral transcriptional response is Erk-dependent (data not shown). 
Furthermore, motif analysis of these 65 gene revealed that about one third of these 
genes contain a hormone receptor motif. At the organismal level, it is known that several 
hormones are secreted in insects upon nutrient uptake that are closely associated with 
reproduction [248-251]. However, the role of various hormones in antiviral immunity 
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remains to be characterized, including the meal-associated hormones [251,252]. 
Subsequent screening of all 65 of the ERK-dependent genes against disparate viruses 
in Drosophila cells revealed that 4 factors have pan-antiviral activity, all of which also 
contain the hormone receptor motif. Surprisingly, all 4 of these genes play a role in 
microtubule and kinetochore assembly. Further investigation into the roles for these 
antiviral factors in vivo may inform us of how ERK signaling helps curb viral replication in 
various tissue compartments. 
In addition to ERK’s antiviral role in gut immunity, we also have preliminary data 
suggesting that ERK signaling is antiviral in other tissue compartments. By directly 
injecting virus into the thoracic cavity, we bypass oral infection and are able to establish 
a systemic infection. Using this approach in heat-shock inducible ERK mutants, we 
found that flies transiently depleted of ERK pathway components using in vivo RNAi 
have higher viral titers and increased mortality than control flies. Future studies will 
involve the identification of specific organ compartments that have this ERK-mediated 
immunity once viral dissemination occurs. 
For an organism to function effectively under varying environmental conditions, 
including pathogen challenge, its organ systems must communicate to adapt in a 
coordinated manner [53]. Disregulation of these homeostatic mechanisms may lead to 
the establishment of systemic infection [53]. Once we define the genes and pathways 
that play fundamental roles in the gut epithelium, including ERK signaling, we can 
extend our studies to focus on inter-organ communication. For instance, it has already 
been shown that bacterial infection of the gut can trigger signals in the fat body for 
antimicrobial peptide secretion via hemocyte signaling [52]. By studying how viral 
infection is sensed by tissues and communicated to other compartments, we can begin 
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dissecting how systemic responses are coordinated to curb systemic viral dissemination. 
This is tractable in Drosophila, because we can combine sophisticated genetic tools 
(e.g., tissue-specific knock outs) with drug feeding to selectively perturb the different 
compartments during infection [145]. We can also combine loss-of-function approaches 
with functional genomics (RNAseq, proteomics) to define the network of interactions 
involved in how ERK prevents the establishment of infection [138]. For example, we can 
perform RNAseq to identify the ERK-dependent genes in vivo and perform rescue 
experiments to determine ERK’s antiviral mode of action in gut enterocytes. This will 
allow us to probe the mechanisms by which these pathways are integrated to restrict 
arboviral infection in insects. 
In conclusion, many (re) emerging pathogens are arthropod-borne, transmitted 
via an insect vector, and cause significant health and agricultural problems worldwide. 
Despite their increasing significance, there are no existing current vaccines or targeted 
therapies. This is at least in part due to our limited understanding of virus-host 
interactions and the mechanisms used by hosts to restrict infection. By using Drosophila 
as a model insect to dissect virus-host interactions, we not only expanding our 
understanding of basic biological processes, but also increasing our understanding of 
antiviral mechanisms at play for insect vectors that carry and spread arboviral disease.  
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